Hidradenitis suppurativa

L12_HIDRADENITISSUP

hidradenitis suppurativa: a common (though rarely diagnosed), chronic skin disease characterized by clusters of abscesses or subcutaneous boil-like "infections" (oftentimes free of actual bacteria) that most commonly affects apocrine sweat gland bearing areas, such as the underarms, under the breasts, inner thighs, groin and buttocks.The disease is not contagious. There are indications that it is hereditary among certain ethnic groups and autoimmune in nature. Onset is most common in the late teens and early 20's.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L73.2 Hospital discharge: ICD-9 — 7058C Cause of death: ICD-10 — L73.2 Cause of death: ICD-9 — 7058C 2 out of 7 registries used, show all original rules.	1728
4. Check minimum number of events None	1728
5. Include endpoints None	1728
6. Filter based on genotype QC (FinnGen only)	1565

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L73
Name in latin: Hidradenitis suppurativa

NAME	L12_HIDRADENITISSUP
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L732
HD_ICD_9	7058C
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L732
COD_ICD_9	7058C
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Hidradenitis suppurativa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	7919	4721	3160
Only index persons	7639	4620	3019
Unadjusted period prevalence (%)
Whole population	0.12	0.14	0.09
Only index persons	0.15	0.17	0.12
Median age at first event (years)
Whole population	38.04	36.15	40.86
Only index persons	37.79	36.01	40.52

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1565	1097	468
Unadjusted period prevalence (%)	0.34	0.39	0.21
Median age at first event (years)	40.93	38.47	46.70

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1631: Matched controls
16310

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

18.9

307.7

486

359

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

14.8

307.7

332

276

J01FF01

ATC

clindamycin; systemic

7.5

307.7

970

2678

S10

ICPC

Boil/carbuncle

18.1

307.7

565

464

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

19.2

307.7

270

167

J01AA04

ATC

lymecycline; systemic

7.8

307.7

693

1407

L73.2

ICD-10 Finland

Hidradenitis suppurativa

15493.5

307.7

1572

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

13.4

299.4

306

276

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

10.9

261.6

308

340

L02.8

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of other sites

17.9

252.5

213

136

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

8.9

247.3

348

482

J04BA02

ATC

dapsone; oral

75.1

231.9

125

J01AA07

ATC

tetracycline; systemic

5.3

223.6

627

1708

L72.1

ICD-10 Finland

Trichilemmal cyst

9.1

210.1

281

363

D05BB02

ATC

acitretin; oral

17.4

183.7

155

D10BA01

ATC

isotretinoin; oral

6.1

180.0

369

749

SPAT1148

SPAT

Treatment of chronic ulcer or burn

6.1

175.6

358

722

L70.0

ICD-10 Finland

Acne vulgaris

11.3

170.3

187

184

QBA10

NOMESCO Finland

Incision of skin of trunk

27.4

159.8

110

A10BA02

ATC

metformin; oral

4.1

155.7

625

2158

J04AB02

ATC

rifampicin; systemic

24.7

155.3

111

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

7.1

143.6

237

384

L05.9

ICD-10 Finland

Pilonidal cyst without abscess

14.2

139.7

131

100

L04AB04

ATC

adalimumab; parenteral

9.2

132.8

169

202

380

Kela drug reimbursment

Adalimumab (hidradenitis suppurativa)

+∞

128.9

122

S97

ICPC

Chronic ulcer skin

7.6

127.3

192

281

QBE05

NOMESCO Finland

Excision of sweat glands or sweat gland bearing skin from trunk

662.5

126.1

123

L73.8

ICD-10 Finland

Other specified follicular disorders

30.1

124.9

L05.0

ICD-10 Finland

Pilonidal cyst with abscess

15.2

115.1

103

J01CF05

ATC

flucloxacillin; systemic

5.0

113.2

273

627

XQ848

NOMESCO Finland

Dermatological photography

10.4

111.2

127

131

N07BA03

ATC

varenicline; oral

5.6

104.8

217

435

E66.01

ICD-10 Finland

Obesity due to excess calories

3.8

101.8

373

1171

P01AB01

ATC

metronidazole; oral, rectal

3.0

101.7

910

4845

TQW80

NOMESCO Finland

Local dermatologic skincare

10.8

101.6

113

112

7058C

ICD-9 Finland

Disorders of sweat glands, Other specified disorders of sweat glands[HIDRADENITIS SUPPURATIVA]

+∞

97.9

SPAT1146

SPAT

Puncture of abscess or incision of skin

11.8

95.9

100

K61.0

ICD-10 Finland

Anal abscess

9.7

90.4

108

118

E0000UV, ,

ATC

2.8

90.2

905

5017

J01DB01

ATC

cefalexin; oral

8.4

88.5

1564

11989

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

6.5

88.2

151

251

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

3.3

87.9

414

1515

L02.0

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of face

10.6

87.5

103

Kela drug reimbursment

Diabetes, insulin-treated

3.1

87.1

478

1914

S18

ICPC

Laceration/cut

2.8

86.9

892

4973

215

Kela drug reimbursment

Diabetes, non-insulin-treated

3.1

84.7

467

1871

T90

ICPC

Diabetes non-insulin dependent

3.1

83.0

435

1691

N02AX02

ATC

tramadol; systemic, rectal

2.6

74.8

785

4328

SPAT1149

SPAT

Suture or treatment of traumatic wound

3.7

72.7

260

791

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

14.3

71.9

J01DA01

ATC

[U] cefalexin

2.7

71.2

1174

7938

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

3.2

70.2

339

1245

E66.8

ICD-10 Finland

Other obesity

4.0

68.9

219

613

K60.3

ICD-10 Finland

Anal fistula

8.2

66.4

115

D07AD01

ATC

clobetasol; topical

3.0

66.2

364

1435

QBE99

NOMESCO Finland

Other excision or repair of lesion of skin of trunk

9.3

66.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

3.4

64.8

275

931

S76

ICPC

Skin infection other

4.7

63.8

155

353

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.4

63.4

755

4320

C03DA01

ATC

spironolactone; oral

3.8

62.8

210

608

D06AX01

ATC

fusidic acid; topical

3.3

60.6

259

879

H02AB06

ATC

prednisolone; systemic

2.3

60.1

856

5252

TQW99

NOMESCO Finland

Other minor procedure on skin

5.5

59.3

120

233

ZZR00

NOMESCO Finland

Flap of skin

10.1

59.3

N76.4

ICD-10 Finland

Abscess of vulva

12.8

58.3

N05AH04

ATC

quetiapine; oral

2.6

57.2

452

2129

T82

ICPC

Obesity

4.2

57.2

165

429

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

3.8

57.0

186

528

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

7.0

56.8

131

S29

ICPC

Skin symptom/complaint other

2.6

56.4

429

1983

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

4.6

56.3

143

337

SPAT1262

SPAT

Handing over of treatment supplies

2.9

54.9

307

1212

C03CA01

ATC

furosemide; systemic

2.8

54.8

321

1299

J01DA09

ATC

[U] cefadroxil

2.4

54.0

555

2932

J01MA02

ATC

ciprofloxacin; systemic

2.3

53.6

643

3626

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

4.0

53.2

164

447

L73.9

ICD-10 Finland

Follicular disorder, unspecified

22.2

52.6

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

3.7

52.3

182

539

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

3.1

51.7

240

852

S04

ICPC

Lump/swelling localized

2.9

51.2

286

1125

G47.3

ICD-10 Finland

Sleep apnoea

2.4

50.8

452

2232

SPAT1263

SPAT

Sampling

2.2

50.7

790

4918

N02AJ06

ATC

codeine and paracetamol; systemic

2.2

50.2

839

5360

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.9

48.3

151

415

D07AC01

ATC

betamethasone; topical

2.2

48.1

666

3938

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

14.1

47.8

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

4.0

47.7

143

381

J01MA12

ATC

levofloxacin; systemic

2.7

47.4

314

1345

A46

ICD-10 Finland

Erysipelas

2.9

47.4

249

945

D95

ICPC

Anal fissure/perianal abscess

8.7

47.0

JHA00

NOMESCO Finland

Anal or perianal incision

7.3

46.4

N06AX11

ATC

mirtazapine; oral

2.1

45.9

655

3901

J01AA02

ATC

doxycycline; systemic

2.4

45.4

1292

9999

N03AX16

ATC

[U] pregabalin

2.4

45.2

399

1952

E66.9

ICD-10 Finland

Obesity, unspecified

4.2

45.1

127

323

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

3.3

45.1

182

592

SPAT1260

SPAT

Consultation of another employee

2.5

44.6

341

1562

E66.00

ICD-10 Finland

Metabolic syndrome

3.8

44.0

145

413

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

5.3

44.0

180

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.2

43.6

195

674

A02BC02

ATC

pantoprazole; systemic

2.1

43.4

1120

8247

L70.1

ICD-10 Finland

Acne conglobata

82.5

43.1

QBB05

NOMESCO Finland

Revision of wound of skin of trunk

9.1

43.0

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

2.5

42.9

339

1574

L40.0

ICD-10 Finland

Psoriasis vulgaris

4.3

41.8

111

270

Z72.0

ICD-10 Finland

Tobacco use

5.0

41.5

193

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

4.6

41.3

101

230

9736

FHL

Subcutaneous tumor removal in operating room or anesthesia

11.3

40.8

UJF32

NOMESCO Finland

Coloscopy

2.3

40.6

396

2011

N06AX12

ATC

bupropion; oral

2.7

40.3

241

976

K05.31

ICD-10 Finland

Periodontitis pronounced

2.9

39.7

214

820

QXB99

NOMESCO Finland

Other procedure to treat skin wound, unspecified location

7.2

39.1

N05BA04

ATC

oxazepam; oral

2.1

39.1

496

2791

N02BE01

ATC

paracetamol; systemic, rectal

3.2

39.0

1499

12718

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.2

38.9

454

2473

D07XC01

ATC

betamethasone; topical

2.8

38.9

225

895

SPAT1301

SPAT

No procedures

2.1

38.8

521

2993

N06AB04

ATC

citalopram; systemic

2.2

38.6

397

2056

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.2

38.0

399

2081

S92

ICPC

Sweat gland disease

136.6

37.9

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

2.6

37.8

258

1114

M79.6

ICD-10 Finland

Pain in limb

2.0

37.5

794

5336

A10AE04

ATC

insulin glargine; parenteral

3.0

37.0

182

663

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

36.7

761

5067

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.8

36.7

197

752

QDA10

NOMESCO Finland

Incision of skin of lower limb

14.6

36.6

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

5.3

36.6

147

A10BJ06

ATC

semaglutide; parenteral

3.4

36.5

137

424

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

3.1

36.5

162

556

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.2

36.5

386

2016

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.3

36.4

342

1701

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

36.4

793

5364

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.9

36.1

180

660

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.5

35.8

255

1122

N03AX12

ATC

[U] gabapentin; oral

2.4

35.6

287

1336

TPH04

NOMESCO Finland

Cathetrisation of vein

2.2

35.4

371

1927

E66

ICD-10 Finland

Obesity

2.9

35.2

175

640

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

34.9

545

3282

R03AC02

ATC

salbutamol; inhalant

1.9

34.8

1005

7416

E11

ICD-10 Finland

Type 2 diabetes mellitus

2.5

34.6

237

1022

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.4

34.6

130

403

R02

ICPC

Shortness of breath/dyspnoea

2.5

34.3

241

1052

D05AX52

ATC

calcipotriol, combinations; topical

3.6

34.2

116

336

E000001, ,

ATC

2.1

34.1

396

2139

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

4.3

34.0

214

C07AB07

ATC

bisoprolol; oral

1.9

33.9

597

3739

L03.3

ICD-10 Finland

Cellulitis of trunk

9.0

33.8

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.9

33.7

976

7175

A06AD11

ATC

lactulose; oral

2.7

33.6

194

768

D07BA04

ATC

hydrocortisone and antiseptics; topical

2.5

33.6

239

1049

L70.8

ICD-10 Finland

Other acne

39.2

33.5

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.0

33.2

546

3337

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.1

33.1

420

2342

D10AF01

ATC

clindamycin; topical

3.2

32.8

141

474

9733

FHL

Excision of skin change in operating room or anesthesia

7.2

32.7

TQW11

NOMESCO Finland

Vacuum treatment of wound

6.0

32.7

N02AA05

ATC

oxycodone; systemic

2.5

32.6

228

992

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

32.4

433

2457

EBA05

NOMESCO Finland

Complicated extraction of tooth

2.0

32.4

450

2590

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.9

32.0

707

4742

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.9

31.7

1016

7644

L04AC10

ATC

secukinumab; parenteral

12.1

31.7

N06AX16

ATC

venlafaxine; oral

2.2

31.7

333

1725

OAB50, ,

SPAT

2.9

31.7

157

573

P17

ICPC

Tobacco abuse

5.9

31.6

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

5.1

31.4

136

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

31.2

618

3998

WX002

NOMESCO Finland

Sedation and analgesia

2.2

31.2

294

1457

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.8

31.0

275

A10BH01

ATC

sitagliptin; oral

3.0

30.8

141

492

M54.5

ICD-10 Finland

Low back pain

1.8

30.5

701

4742

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

4.4

30.5

180

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

6.5

30.4

L72.0

ICD-10 Finland

Epidermal cyst

8.1

30.3

SPAT1254

SPAT

Administration of medicine

2.4

30.2

247

1151

R95

ICPC

Chron obstructive pulmonary disease

6.0

30.2

I10

ICD-10 Finland

Essential (primary) hypertension

1.8

30.0

718

4909

SPAT1249

SPAT

Treatment-related counselling outside office

1.8

30.0

695

4706

WX110

NOMESCO Finland

Infiltration anesthesia

2.0

29.8

1295

10651

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

29.6

342

1832

J02AC01

ATC

fluconazole; systemic

1.8

29.4

751

5229

EBA00

NOMESCO Finland

Extraction of tooth

1.8

29.2

696

4743

SPAT1153

SPAT

Removal of sutures

1.9

29.1

445

2633

J01XC01

ATC

fusidic acid; systemic

6.2

29.0

D07AB08

ATC

desonide; topical

2.4

28.9

222

1006

A10BK03

ATC

empagliflozin; oral

2.7

28.8

172

691

ZY010

NOMESCO Finland

Hospital outpatient

2.8

28.5

153

582

R96

ICPC

Asthma

2.5

28.0

185

781

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

4.8

27.9

138

L17

ICPC

Foot/toe symptom/complaint

1.9

27.9

521

3282

L71.8

ICD-10 Finland

Other rosacea

9.1

27.8

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.9

27.6

480

2956

M01AE03

ATC

ketoprofen; systemic, rectal

1.8

27.4

540

3455

P76

ICPC

Depressive disorder

2.4

27.3

199

880

Z3231

NOMESCO Finland

Registered nurse

1.9

27.2

436

2611

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

27.2

422

2501

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

27.1

351

1954

L04AX03

ATC

methotrexate; systemic

2.5

27.1

190

825

S99

ICPC

Skin disease other

5.3

27.0

107

N61

ICD-10 Finland

Inflammatory disorders of breast

3.4

26.9

101

312

L70.9

ICD-10 Finland

Acne, unspecified

7.9

26.9

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.9

26.8

221

SPAT1310

SPAT

Counselling related to known health issue

1.8

26.7

535

3435

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.8

26.5

864

6386

D07AC13

ATC

mometasone; topical

1.8

26.1

488

3064

K50.8

ICD-10 Finland

Other Crohn disease

4.9

26.1

122

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.1

26.1

117

403

SPAT1240

SPAT

Therapeutic discussion

2.1

26.0

268

1370

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.2

25.9

249

1237

L28

ICPC

Limited function/disability (L)

2.2

25.7

239

1171

N05CF01

ATC

zopiclone; oral

1.9

25.7

466

2897

SPAT1151

SPAT

Treatment of major wounds

10.2

25.6

ZZA00

NOMESCO Finland

Split skin graft

5.3

25.4

H60.0

ICD-10 Finland

Abscess of external ear

9.5

25.3

N06AB10

ATC

escitalopram; oral

1.9

25.3

455

2819

N06AX21

ATC

duloxetine; oral

2.2

25.3

245

1221

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.8

25.2

136

518

L08.0

ICD-10 Finland

Pyoderma

7.5

25.1

L04AX01

ATC

azathioprine; systemic

3.3

25.0

311

M54.4

ICD-10 Finland

Lumbago with sciatica

2.0

25.0

353

2020

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

24.8

215

1024

N05AX08

ATC

risperidone; systemic

2.6

24.5

147

591

QX3HE

NOMESCO Finland

Ultrsound examination of lesion close to skin

5.5

24.4

J01DB05

ATC

cefadroxil; oral

3.1

24.3

106

359

K02.1

ICD-10 Finland

Caries of dentine

1.8

24.3

1116

8985

SPAT1283

SPAT

Restricted health certificate

1.8

24.3

457

2866

N06AB06

ATC

sertraline; oral

2.1

24.1

267

1399

J01FA01

ATC

erythromycin; systemic

2.0

24.0

306

1688

A10BJ05

ATC

dulaglutide; parenteral

4.9

23.7

112

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.2

23.7

223

1097

WX290

NOMESCO Finland

Other blockage of nerve

1.7

23.5

969

7538

WX402

NOMESCO Finland

General anaesthesia

1.9

23.4

403

2453

Z2446

NOMESCO Finland

Social worker

2.6

23.4

140

562

QBB10, ,

SPAT

5.8

23.4

L88

ICD-10 Finland

Pyoderma gangrenosum

47.4

23.4

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

4.9

23.2

110

P99

ICPC

Psychological disorders other

3.2

23.2

315

D11

ICPC

Diarrhoea

2.0

23.2

278

1498

N05AA02

ATC

levomepromazine; systemic

3.3

23.2

284

N06AB03

ATC

fluoxetine; oral

2.1

23.1

236

1198

A03

ICPC

Fever

1.9

23.0

395

2402

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

7.0

23.0

A28

ICPC

Limited function/disability NOS

2.4

22.9

176

794

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

22.9

432

2702

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.1

22.9

244

1259

L03

ICPC

Low back symptom/complaint

1.7

22.7

542

3629

ZXC07

NOMESCO Finland

Carbon dioxide laser

84.7

22.7

QBG99

NOMESCO Finland

Other operation for chronic ulcer or fistula of skin

121.7

22.6

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.3

22.6

194

918

R06.0

ICD-10 Finland

Dyspnoea

1.8

22.4

393

2402

N03AX09

ATC

lamotrigine; oral

2.6

22.4

137

556

N05AH02

ATC

clozapine; systemic

4.1

22.3

156

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

22.1

378

2291

R05

ICPC

Cough

1.8

22.1

450

2876

A10AB05

ATC

insulin aspart; parenteral

2.6

22.0

136

555

S01

ICPC

Pain/tenderness of skin

3.0

21.8

332

H02AB07

ATC

prednisone; oral

2.2

21.8

206

1013

S06

ICPC

Rash localized

2.9

21.8

104

371

SPAT1222

SPAT

Counselling/guidance promoting independent living

2.2

21.7

190

907

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.2

21.7

207

1023

SPAT1211

SPAT

Application of soft bandage

2.4

21.6

151

653

L40.3

ICD-10 Finland

Pustulosis palmaris et plantaris

5.4

21.4

N05AH03

ATC

olanzapine; systemic

2.4

21.4

155

681

G03HB01

ATC

cyproterone and estrogen; oral

2.0

21.4

248

1319

L72.9

ICD-10 Finland

Follicular cyst of skin and subcutaneous tissue, unspecified

17.7

21.4

G56.0

ICD-10 Finland

Carpal tunnel syndrome

2.0

21.3

249

1327

C07AA05

ATC

propranolol; systemic

1.8

21.3

401

2500

UJF92

NOMESCO Finland

Capsular endoscopy

4.1

21.2

144

R03BB04

ATC

tiotropium bromide; inhalant

2.6

21.2

128

516

J01FA06

ATC

roxithromycin; oral

1.7

21.2

623

4396

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

21.1

373

2282

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.8

21.0

111

418

H60.9

ICD-10 Finland

Otitis externa, unspecified

2.3

20.6

172

803

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.1

20.6

202

1007

UJF30

NOMESCO Finland

Ileoscopy through colon

2.3

20.6

177

837

P29

ICPC

Psychological sympt/compl other

2.1

20.5

211

1072

B01AB05

ATC

enoxaparin; parenteral

1.8

20.5

427

2739

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

3.7

20.4

185

S21

ICPC

Skin texture symptom/complaint

2.0

20.3

251

1363

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.9

20.3

158

ZYC01

NOMESCO Finland

Remote contact by phone

2.5

20.3

138

589

QXB99, ,

SPAT

3.9

20.2

154

SAA01

NOMESCO Finland

Simple examination of mouth

1.8

20.1

1296

11124

R50.9

ICD-10 Finland

Fever, unspecified

1.9

20.1

271

1518

EBA15

NOMESCO Finland

Extraction of multiple teeth

3.4

20.0

227

L03.9

ICD-10 Finland

Cellulitis, unspecified

4.2

19.9

129

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.9

19.9

313

1842

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

19.9

247

1344

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

19.9

529

3623

A02BC03

ATC

lansoprazole; oral

1.8

19.8

386

2426

N05AX12

ATC

aripiprazole; systemic

2.6

19.6

121

493

R06AE07

ATC

cetirizine; oral

1.6

19.5

782

5925

N05BA01

ATC

diazepam; systemic, rectal

2.1

19.4

206

1058

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.0

19.4

316

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

19.3

162

758

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

19.3

100

373

A10BK01

ATC

dapagliflozin; oral

2.6

19.3

118

479

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

4.9

19.2

N07BB01

ATC

disulfiram; oral

2.9

19.2

345

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

2.7

19.2

104

397

K04.08

ICD-10 Finland

Other specified pulpit

2.1

19.1

202

1036

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.5

19.1

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

3.2

19.0

250

C10AA05

ATC

atorvastatin; oral

1.7

19.0

452

2999

N05CD07

ATC

temazepam; oral

2.5

18.9

124

520

C10AA01

ATC

simvastatin; oral

1.8

18.9

355

2203

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.2

18.9

170

819

A10BB12

ATC

glimepiride; oral

3.5

18.8

186

L30.4

ICD-10 Finland

Erythema intertrigo

5.7

18.7

A02BC01

ATC

omeprazole; systemic

1.7

18.7

388

2476

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

18.7

358

2233

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

2.2

18.7

167

802

N03AG01

ATC

valproic acid; systemic, rectal

2.5

18.7

123

517

XCK10

NOMESCO Finland

Photography of fundus of eye

2.5

18.7

123

517

SPAT1058

SPAT

PEF monitoring instruction

2.5

18.6

125

530

C08CA01

ATC

amlodipine; oral

1.7

18.6

403

2602

K50.9

ICD-10 Finland

Crohn disease, unspecified

4.5

18.5

102

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.0

18.4

233

1274

L84

ICD-10 Finland

Corns and callosities

3.5

18.4

184

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

18.3

275

1591

H01

ICPC

Ear pain/earache

1.9

18.3

256

1447

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

18.3

386

2472

N05AN01

ATC

lithium; oral

3.3

18.3

214

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

3.0

18.3

277

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

4.7

18.3

E66.0

ICD-10 Finland

Obesity due to excess calories

7.2

18.3

QCB10

NOMESCO Finland

Major dressing of wound of skin of upper limb

4.0

18.2

129

L01BA01

ATC

methotrexate; systemic

3.4

18.2

200

SPAT1312

SPAT

General health counselling

1.6

18.1

527

3675

A10BJ02

ATC

liraglutide; parenteral

3.4

18.0

196

J01CF02

ATC

cloxacillin; systemic

4.7

18.0

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.1

18.0

197

1022

L02.1

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of neck

5.9

17.9

205

Kela drug reimbursment

Chronic hypertension

2.0

17.9

217

1168

L86

ICPC

Back syndrome with radiating pain

2.5

17.9

117

490

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

2.0

17.8

217

1171

M25.5

ICD-10 Finland

Pain in joint

1.6

17.8

588

4227

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

17.6

290

1725

9734

FHL

Excision and local plastic or associated free skin grafting

14.7

17.6

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

17.6

180

911

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.6

17.6

107

433

68599

ICD-8 Finland

Pilonidal cyst

15.8

17.5

J20

ICD-10 Finland

Acute bronchitis

2.0

17.5

197

1033

R5140

NOMESCO Finland

Monitoring the use of the aid

2.1

17.5

169

837

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

17.4

315

1928

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

2.1

17.4

170

845

K50.0

ICD-10 Finland

Crohn disease of small intestine

4.2

17.3

112

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

3.6

17.3

162

WZC00

NOMESCO Finland

Treatment plan or consultation

1.6

17.3

616

4501

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.6

17.2

494

3426

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

6.7

17.0

D07CC01

ATC

betamethasone and antibiotics; topical

2.0

17.0

211

1144

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.0

17.0

208

1123

WZC30

NOMESCO Finland

Teaching

1.9

17.0

243

1383

R60.0

ICD-10 Finland

Localized oedema

2.1

16.9

165

819

ZXE00

NOMESCO Finland

One hour or less

1.6

16.9

605

4417

D07BC01

ATC

betamethasone and antiseptics; topical

2.1

16.9

182

938

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

2.1

16.9

161

793

N02BF01

ATC

gabapentin; oral

2.1

16.7

180

928

TPH07

NOMESCO Finland

Cathetrisation of artery

2.3

16.6

138

642

A10BD07

ATC

metformin and sitagliptin; systemic

3.3

16.5

192

QBG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of trunk

23.3

16.4

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

4.5

16.4

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

3.4

16.4

178

6851A

ICD-9 Finland

Pilonidal cyst, Without mention of abscess

14.4

16.3

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

3.7

16.3

140

L68.0

ICD-10 Finland

Hirsutism

15.5

16.2

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

4.1

16.2

109

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.2

16.1

137

644

L71.9

ICD-10 Finland

Rosacea, unspecified

3.9

16.1

123

L40.8

ICD-10 Finland

Other psoriasis

13.7

16.0

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

16.0

138

653

SFA20

NOMESCO Finland

Two-surface restoration

1.6

15.9

1039

8634

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

15.8

561

4073

N06AX05

ATC

trazodone; oral

3.3

15.8

182

K08.3

ICD-10 Finland

Retained dental root

2.3

15.8

120

538

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.4

15.7

116

513

J96.1

ICD-10 Finland

Chronic respiratory failure

5.9

15.7

F17.2

ICD-10 Finland

Mental and behavioural disorders due to use of tobacco, dependence syndrome

4.9

15.7

SFA10

NOMESCO Finland

One-surface restoration

1.5

15.7

976

8013

9752

FHL

Surgical treatment of hyperhidrosis

+∞

15.6

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.3

15.6

124

567

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

3.5

15.6

159

160

Kela drug reimbursment

exenatide

4.3

15.6

A99

ICPC

Disease/condition unspecnature/site

2.0

15.5

168

868

N06AX03

ATC

mianserin; oral

2.8

15.5

281

D10

ICPC

Vomiting

2.1

15.5

158

798

A07EC02

ATC

mesalazine; oral, rectal

2.5

15.5

103

435

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

15.5

480

3375

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.0

15.5

180

954

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

15.4

383

2548

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

15.4

117

524

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.1

15.4

211

RD210, ,

NOMESCO Finland

3.9

15.3

114

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.5

15.2

101

426

ZXE10

NOMESCO Finland

More than one and less than three hours

1.6

15.2

484

3421

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

15.1

105

452

ZXA10

NOMESCO Finland

Bilateral

1.8

15.1

236

1378

M01AH05

ATC

etoricoxib; oral

1.5

15.1

1004

8331

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

15.1

152

764

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

15.1

141

689

AA1AD

NOMESCO Finland

CT of head and brain

1.7

15.0

329

2116

L02

ICPC

Back symptom/complaint

1.9

15.0

214

1214

Z3229

NOMESCO Finland

Other healthcare associate professional

2.3

14.9

118

538

ZX120

NOMESCO Finland

Intravenous

2.2

14.8

136

659

WZC00, ,

SPAT

1.8

14.8

258

1558

J46

ICD-10 Finland

Status asthmaticus

3.2

14.6

191

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.0

14.6

178

958

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

14.6

146

70591

ICD-8 Finland

Diseases of sweat glands, Hidrosadenitis

+∞

14.6

X59

ICD-10 Finland

Exposure to unspecified factor

1.7

14.5

307

1955

R4190

NOMESCO Finland

Nutritional therapy

2.6

14.5

344

ZXD05

NOMESCO Finland

Urgent procedure

1.6

14.5

485

3462

H03AA01

ATC

levothyroxine sodium; systemic

1.7

14.4

347

2286

L30.3

ICD-10 Finland

Infective dermatitis

2.9

14.4

247

K05.30

ICD-10 Finland

Periodontitis complex

1.8

14.3

221

1284

J01CA04

ATC

amoxicillin; systemic

1.7

14.3

1385

12453

A01

ICPC

Pain general/multiple sites

2.0

14.3

165

872

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

14.2

127

609

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.8

14.2

232

1372

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

14.2

233

1380

R07

ICPC

Sneezing/nasal congestion

2.0

14.1

156

811

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

14.1

104

460

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

3.9

14.1

107

R74

ICPC

Upper respiratory infection acute

1.5

14.0

696

5400

QBE20

NOMESCO Finland

Excision and repair of scar or web of skin of trunk

5.5

14.0

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

14.0

477

3415

P03

ICPC

Feeling depressed

1.8

13.9

249

1512

SGA01

NOMESCO Finland

Emergency treatment

1.6

13.9

338

2232

A29

ICPC

General symptom/complaint other

1.9

13.9

196

1108

V03AA01, ,

ATC

5.1

13.9

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.6

13.9

444

3132

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

3.0

13.8

214

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.6

13.8

132

SPA47

NOMESCO Finland

Precision impression for denture

3.6

13.8

132

Z00.0

ICD-10 Finland

General medical examination

1.7

13.7

296

1893

K04.0

ICD-10 Finland

Pulpitis

1.8

13.7

207

1195

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.7

13.7

276

1734

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

4.0

13.7

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.1

13.6

127

619

UKC02

NOMESCO Finland

Cystoscopy

2.0

13.6

160

850

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

4.7

13.6

D06

ICPC

Abdominal pain localized other

1.9

13.5

169

917

B01AC04

ATC

clopidogrel; oral

2.1

13.5

136

683

ZXD10

NOMESCO Finland

Scheduled procedure

1.5

13.5

510

3728

ZXA05

NOMESCO Finland

Left side

1.7

13.5

280

1771

R51.80

ICD-10 Finland

Headache

1.7

13.5

313

2039

N05AD01

ATC

haloperidol; systemic

3.5

13.5

134

N06AA09

ATC

amitriptyline; systemic

2.1

13.5

125

608

N02BF02

ATC

pregabalin; oral

2.2

13.5

118

561

A07EC01

ATC

sulfasalazine; oral, rectal

2.1

13.5

131

649

R11

ICD-10 Finland

Nausea and vomiting

2.0

13.5

155

817

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.9

13.5

228

L04AD01

ATC

ciclosporin; systemic

3.8

13.5

106

Z04.4

ICD-10 Finland

Examination and observation following alleged rape and seduction

5.1

13.4

A10BX07

ATC

[U] liraglutide

5.1

13.4

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

2.8

13.4

257

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

13.4

189

1068

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

13.3

1025

8656

A02BC05

ATC

esomeprazole; systemic

1.5

13.3

578

4352

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

4.2

13.2

9731

FHL

Opening and channeling of the inflammatory site in the operating room or anesthesia

13.9

13.2

M03BX02

ATC

tizanidine; oral

1.5

13.2

1016

8567

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.8

13.2

217

1284

WX320

NOMESCO Finland

Spinalanesthesy

1.6

13.2

332

2208

XQ802

NOMESCO Finland

Epicutan test

2.5

13.2

336

L05

ICPC

Flank/axilla symptom/complaint

2.2

13.1

110

514

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.7

13.1

277

J01CE02

ATC

phenoxymethylpenicillin; oral

1.5

13.0

1160

10067

F32

ICD-10 Finland

Depressive episode

2.1

13.0

125

617

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

13.0

357

2424

XQ845

NOMESCO Finland

Dermatoscopy

4.2

13.0

J01MA14

ATC

moxifloxacin; systemic

2.1

12.9

130

653

D07AA02

ATC

hydrocortisone; topical

1.7

12.9

250

1551

WX702

NOMESCO Finland

Supraglottic ventilation device

2.3

12.9

433

R06.5

ICD-10 Finland

Mouth breathing

2.0

12.9

149

787

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

12.9

392

2726

OAB72

NOMESCO Finland

Weight control and weight loss guidance

4.1

12.9

SPAT1229

SPAT

Assessment of need for aid

2.5

12.8

316

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

2.2

12.8

104

480

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.9

12.8

169

934

SFA30

NOMESCO Finland

Three-surface restoration

1.5

12.8

667

5199

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

12.8

171

949

A07EA06

ATC

budesonide; oral, local oral

2.6

12.7

299

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.6

12.7

311

2052

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.9

12.7

208

Z02.7

ICD-10 Finland

Issue of medical certificate

2.0

12.6

133

680

R52.2

ICD-10 Finland

Other chronic pain

2.6

12.6

295

P72

ICPC

Schizophrenia

3.2

12.6

161

SPAT1255

SPAT

Intravenous administration of medicine

2.3

12.5

413

A10AC01

ATC

insulin (human); parenteral

2.1

12.5

118

578

N05AF03

ATC

chlorprothixene; systemic

3.0

12.5

188

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

12.5

216

1298

L75.9

ICD-10 Finland

Apocrine sweat disorder, unspecified

131.0

12.4

-1, ,

NOMESCO Finland

1.5

12.4

597

4570

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

3.2

12.4

157

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

12.3

233

1436

WX003

NOMESCO Finland

Sedation or analgesia orally, rectally or intramuscularly without general anesthesia

4.2

12.3

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

12.2

130

666

L15

ICPC

Knee symptom/complaint

1.6

12.2

374

2602

JHD20

NOMESCO Finland

Incision of fistula-in-ano

5.0

12.2

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.9

12.2

163

905

E11.3

ICD-10 Finland

Type 2 diabetes mellitus, with ophthalmic complications

3.6

12.2

114

EBA30

NOMESCO Finland

Extraction of root of tooth

2.4

12.1

381

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

3.3

12.1

139

L08

ICPC

Shoulder symptom/complaint

1.6

12.1

340

2319

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.3

12.0

433

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

12.0

231

WX725

NOMESCO Finland

Noninvasive ventilation

2.3

12.0

414

F32.1

ICD-10 Finland

Moderate depressive episode

1.9

12.0

154

843

M01AH01

ATC

celecoxib; oral

1.7

12.0

216

1312

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

12.0

303

2013

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

5.7

12.0

N75.1

ICD-10 Finland

Abscess of Bartholin gland

4.6

11.9

P74

ICPC

Anxiety disorder/anxiety state

2.0

11.9

125

638

N49.9

ICD-10 Finland

Inflammatory disorder of unspecified male genital organ

47.0

11.9

Z3226

NOMESCO Finland

Physiotherapist

1.7

11.9

248

1569

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

11.8

183

F61.0

ICD-10 Finland

Mixed personality disorders

3.3

11.8

136

D64.9

ICD-10 Finland

Anaemia, unspecified

2.2

11.8

103

490

D02AX

ATC

Other emollients and protectives

2.8

11.7

217

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

9.7

11.7

EB1VA, ,

NOMESCO Finland

1.6

11.7

315

2122

P06

ICPC

Sleep disturbance

1.7

11.7

242

1526

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.5

11.7

518

3892

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.7

11.7

256

1639

S19

ICPC

Skin injury other

2.6

11.7

264

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.8

11.6

176

1015

R52.9

ICD-10 Finland

Pain, unspecified

1.8

11.6

168

955

S80.0

ICD-10 Finland

Contusion of knee

1.9

11.6

148

808

T89

ICPC

Diabetes insulin dependent

2.3

11.6

369

H60.8

ICD-10 Finland

Other otitis externa

2.6

11.6

259

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.6

11.6

277

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

2.0

11.5

122

624

SPAT1284

SPAT

Extensive health certificate

2.8

11.5

208

M79.1

ICD-10 Finland

Myalgia

1.6

11.5

277

1817

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.8

11.5

195

1164

P15

ICPC

Chronic alcohol abuse

2.7

11.5

237

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.9

11.5

181

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

2.6

11.4

249

SPAT1139

SPAT

Nutrition survey

3.0

11.4

165

SPAT1299

SPAT

Other function in accordance with podiatry nomenclature

4.7

11.4

SPE01

NOMESCO Finland

Mucosa-supported partial denture

3.7

11.4

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.9

11.4

160

901

SPAT1305

SPAT

Counselling and guidance related to physical exercise

2.0

11.4

131

691

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

2.8

11.4

204

D01

ICPC

Abdominal pain/cramps general

1.7

11.4

232

1458

S20

ICPC

Corn/callosity

3.8

11.3

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.9

11.3

150

830

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

4.3

11.3

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.6

11.3

257

X58

ICD-10 Finland

Exposure to other specified factors

1.6

11.2

257

1664

N05BA06

ATC

lorazepam; systemic, sublingual

2.5

11.2

306

SPAT1097

SPAT

Recording of ECG

1.9

11.2

156

877

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

11.2

215

1329

N01

ICPC

Headache

1.6

11.1

253

1634

6850A

ICD-9 Finland

Pilonidal cyst, With abscess

20.2

11.1

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.3

11.1

131

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.7

11.1

235

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

11.1

392

2805

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.6

11.1

253

SPAT1210

SPAT

Application of cast or individual aid

2.5

11.1

271

M01AB05

ATC

diclofenac; systemic, rectal

1.4

11.1

1005

8601

WVA20, ,

SPAT

2.6

11.0

260

L16

ICPC

Ankle symptom/complaint

1.7

11.0

211

1304

ZXA00

NOMESCO Finland

Right side

1.6

11.0

290

1944

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

11.0

192

1156

R5110, ,

SPAT

2.1

11.0

100

484

A02BA02

ATC

ranitidine; systemic

1.7

10.9

213

1322

M48.0

ICD-10 Finland

Spinal stenosis

2.0

10.9

114

581

R60.9

ICD-10 Finland

Oedema, unspecified

2.4

10.9

335

IGY02, ,

SPAT

3.2

10.9

138

H60.3

ICD-10 Finland

Other infective otitis externa

2.9

10.9

170

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

10.8

345

2413

J01FA10

ATC

azithromycin; systemic

1.4

10.8

991

8477

SPAT1285

SPAT

Provision of consultation response

2.3

10.8

355

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.0

10.8

112

569

SPAT1252

SPAT

Overall medication plan or its review

2.4

10.8

299

D05AX02

ATC

calcipotriol; topical

2.8

10.8

193

K04.7

ICD-10 Finland

Periapical abscess without sinus

2.1

10.7

100

488

C09AA05

ATC

ramipril; oral

1.7

10.7

223

1407

K04.00

ICD-10 Finland

Hyperemia of pulp

2.1

10.7

106

529

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

3.3

10.7

124

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.9

10.7

166

K08.80

ICD-10 Finland

Toothache NOS

1.8

10.7

183

1094

R03BA01

ATC

beclometasone; inhalant

1.7

10.7

195

1187

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.6

10.7

246

L11

ICPC

Wrist symptom/complaint

1.8

10.7

178

1057

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.8

10.6

173

1019

K04.1

ICD-10 Finland

Necrosis of pulp

1.7

10.6

199

1220

B02AA02

ATC

tranexamic acid; systemic

1.6

10.6

258

1693

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

3.1

10.6

140

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

10.6

380

2724

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

10.6

106

531

A10BG03

ATC

pioglitazone; oral

3.8

10.6

TUPKY, ,

NOMESCO Finland

4.3

10.6

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.1

10.6

100

491

A10AE05

ATC

insulin detemir; parenteral

2.3

10.5

359

KMAK, ,

NOMESCO Finland

1.4

10.5

879

7380

N05AB01

ATC

dixyrazine; systemic

5.1

10.5

XG466

NOMESCO Finland

Sleep oxymetry

3.1

10.5

141

L21.0

ICD-10 Finland

Seborrhoea capitis

4.8

10.5

E28.2

ICD-10 Finland

Polycystic ovarian syndrome

2.9

10.5

179

H70

ICPC

Otitis externa

3.0

10.5

152

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.3

10.4

121

WX400

NOMESCO Finland

Inhalation anesthesy

2.3

10.4

342

OAB72, ,

SPAT

3.1

10.4

142

TNX33

NOMESCO Finland

Custom moulded cast, unspecified region

2.3

10.4

349

S85

ICPC

Pilonidal cyst/fistula

16.1

10.4

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

10.4

171

1012

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

10.3

256

1688

SPAT1104

SPAT

Monitoring of emergency patient

2.2

10.3

408

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

10.3

169

998

M01AE02

ATC

naproxen; oral, rectal

1.4

10.3

925

7855

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.0

10.3

105

531

R22.2

ICD-10 Finland

Localized swelling, mass and lump, trunk

2.4

10.2

294

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.4

10.2

301

R20.2

ICD-10 Finland

Paraesthesia of skin

1.9

10.2

128

696

H3603, E103,

ICD-10 Finland

4.2

10.1

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.3

10.1

334

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

10.0

678

5471

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.8

10.0

162

952

N05CF02

ATC

zolpidem; oral

1.6

10.0

263

1757

L89

ICD-10 Finland

Decubitus ulcer and pressure area

4.5

10.0

T81.9

ICD-10 Finland

Unspecified complication of procedure

3.4

10.0

104

E000003, ,

ATC

2.3

10.0

335

N06AA06

ATC

trimipramine; systemic

3.1

10.0

140

SPAT1216

SPAT

Assessment of functional ability

1.8

10.0

149

855

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.6

10.0

246

1619

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.7

10.0

206

1297

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.9

10.0

162

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.1

9.9

428

H36.01

ICD-10 Finland

Diabetic maculopathy

4.2

9.9

M54.3

ICD-10 Finland

Sciatica

2.1

9.9

442

OAB42, ,

SPAT

1.6

9.9

225

1452

R21

ICPC

Throat symptom/complaint

1.5

9.9

440

3291

J45

ICD-10 Finland

Asthma

1.7

9.8

174

1050

G44.2

ICD-10 Finland

Tension-type headache

1.6

9.8

243

1601

H13

ICPC

Plugged feeling ear

1.6

9.8

229

1487

C10AA07

ATC

rosuvastatin; oral

1.5

9.8

401

2948

162

Kela drug reimbursment

liraglutide

4.4

9.8

F34.1

ICD-10 Finland

Dysthymia

2.2

9.8

364

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.8

9.8

169

M79.7

ICD-10 Finland

Fibromyalgia

2.4

9.8

300

D01AC02

ATC

miconazole; topical

2.1

9.8

478

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.0

9.8

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.2

9.8

116

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

2.1

9.8

465

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.9

9.7

153

A10AE06

ATC

insulin degludec; parenteral

2.4

9.7

276

D10AX03

ATC

azelaic acid; topical

1.8

9.7

165

984

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

9.7

101

514

J01DA06

ATC

[U] cefuroxime

1.6

9.7

216

1386

N05BE01

ATC

buspirone; oral

2.6

9.7

216

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

2.8

9.7

176

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

3.2

9.6

122

A05

ICPC

Feeling ill

1.9

9.6

130

723

R78

ICPC

Acute bronchitis/bronchiolitis

3.2

9.6

117

L14

ICPC

Leg/thigh symptom/complaint

1.9

9.6

117

630

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

2.8

9.6

177

H60

ICD-10 Finland

Otitis externa

2.0

9.6

104

538

C01DA14

ATC

isosorbide mononitrate; oral

2.2

9.5

395

K04.09

ICD-10 Finland

Pulpit UNS

2.0

9.5

103

532

J01FA09

ATC

clarithromycin; systemic

1.4

9.5

487

3734

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

9.5

126

697

D02AE01

ATC

carbamide; topical

2.0

9.5

484

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.8

9.5

152

892

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

4.1

9.4

E000006, ,

ATC

2.0

9.4

485

L20.0

ICD-10 Finland

Besnier prurigo

1.7

9.4

164

986

L21.8

ICD-10 Finland

Other seborrhoeic dermatitis

4.3

9.4

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

12.4

9.4

E000002, ,

ATC

1.7

9.4

184

1143

F03

ICPC

Eye discharge

1.9

9.3

123

679

SPAT1360

SPAT

Extensive global examination

2.1

9.3

412

N08.39*E11.2

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic nephropathy

4.7

9.3

QDB10, ,

SPAT

3.1

9.3

125

L30.0

ICD-10 Finland

Nummular dermatitis

2.5

9.3

239

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

2.0

9.3

509

N05AB03

ATC

perphenazine; systemic, rectal

2.4

9.3

270

L12

ICPC

Hand/finger symptom/complaint

1.5

9.2

284

1965

R03BA05

ATC

fluticasone; inhalant

1.5

9.2

278

1915

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.2

9.2

347

LCA06

NOMESCO Finland

Biopsy of endometrium

1.7

9.2

186

1163

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.2

9.2

367

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

2.1

9.2

414

B07.9

ICD-10 Finland

Verruca simplex

2.3

9.2

328

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

9.2

450

3418

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.6

9.2

216

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.8

9.2

164

M04AA01

ATC

allopurinol; systemic

2.0

9.2

103

539

M10.9

ICD-10 Finland

Gout, unspecified

2.3

9.1

284

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.2

9.1

355

R4110

NOMESCO Finland

Physiotherapy

1.5

9.1

361

2632

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

3.6

9.1

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.1

9.1

389

C10AA04

ATC

fluvastatin; oral

2.3

9.1

285

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

4.6

9.1

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

9.1

150

888

ZXE20

NOMESCO Finland

More than three and less than five hours

1.7

9.1

156

934

M01AH02

ATC

rofecoxib; oral

1.8

9.0

130

738

N06AX26

ATC

vortioxetine; oral

1.7

9.0

159

958

Z71.8

ICD-10 Finland

Other specified counselling

1.4

9.0

572

4544

K59.09

ICD-10 Finland

Constipation, unspecified

2.1

9.0

390

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.1

9.0

432

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.8

8.9

155

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

2.6

8.9

201

C10AC01

ATC

colestyramine; oral

2.7

8.9

172

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.1

8.9

426

I83.1

ICD-10 Finland

Varicose veins of lower extremities with inflammation

3.7

8.9

XQ800

NOMESCO Finland

Prick test

1.8

8.9

137

794

ACC51

NOMESCO Finland

Release of median nerve

1.9

8.9

112

610

B37.08

ICD-10 Finland

Other candidal stomatitis

8.0

8.9

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.1

8.8

434

L04AA13

ATC

[U] leflunomide

3.0

8.8

134

E11.5

ICD-10 Finland

Type 2 diabetes mellitus, with peripheral circulatory complications

4.5

8.8

C09AA02

ATC

enalapril; systemic

1.7

8.8

166

1019

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.4

8.8

512

4005

P01

ICPC

Feeling anxious/nervous/tense

1.5

8.8

305

2164

-50

ICPC

Medication/prescr/renewal

2.4

8.8

239

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.1

8.8

401

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

3.2

8.8

103

ZX112

NOMESCO Finland

Subcutaneous

3.4

8.8

Z2445

NOMESCO Finland

Psychologist

2.1

8.8

408

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.9

8.8

104

555

CKD05

NOMESCO Finland

Puncture of vitreous body with injection of medication

2.9

8.7

135

T78.4

ICD-10 Finland

Allergy, unspecified

2.0

8.7

457

ICB06, ,

NOMESCO Finland

3.9

8.7

J01EA01

ATC

trimethoprim; systemic

1.5

8.7

352

2576

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.2

8.7

310

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.2

8.6

311

S42.3

ICD-10 Finland

Fracture of shaft of humerus

4.8

8.6

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

8.6

100

530

D09AB01

ATC

zinc bandage without supplements; topical

3.6

8.6

R53

ICD-10 Finland

Malaise and fatigue

1.4

8.6

392

2935

S93

ICPC

Sebaceous cyst

7.0

8.5

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.3

8.5

261

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

2.5

8.5

218

S11

ICPC

Skin infection post-traumatic

3.8

8.5

WX704

NOMESCO Finland

Intubation

1.8

8.5

119

670

R70.0

ICD-10 Finland

Elevated erythrocyte sedimentation rate

3.4

8.5

IGV01

NOMESCO Finland

Psychiatric network contact

3.3

8.5

S89.9

ICD-10 Finland

Unspecified injury of lower leg

2.2

8.5

313

56510

ICD-8 Finland

Anal fissure and fistula, Anal fistula

27.7

8.5

F01

ICPC

Eye pain

2.3

8.5

262

L60.0

ICD-10 Finland

Ingrowing nail

2.2

8.5

333

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

8.5

407

3075

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

8.5

100

533

C09CA06

ATC

candesartan; oral

1.5

8.4

320

2310

LFB10

NOMESCO Finland

Excision of lesion of vulva or perineum

3.9

8.4

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.0

8.4

449

M13.9

ICD-10 Finland

Arthritis, unspecified

1.9

8.4

113

628

N03AE01

ATC

clonazepam; systemic

2.1

8.4

381

ZYC06

NOMESCO Finland

Real-time text-based remote transaction

12.8

8.4

319

Kela drug reimbursment

Adalimumab, brodalumab, certolizumab pegol, etanercept, guselkumab, infliximab, ixekizumab, risankizumab, sekukinumab and ustekinumab (skin psoriasis)

6.7

8.4

K65.0

ICD-10 Finland

Acute peritonitis

4.7

8.4

E10.9

ICD-10 Finland

Type 1 diabetes mellitus, Without complications

2.1

8.4

375

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

4.0

8.3

J01MA01

ATC

ofloxacin; systemic

2.0

8.3

493

B35.3

ICD-10 Finland

Tinea pedis

2.1

8.3

389

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

8.3

1500

14170

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

8.3

124

712

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

8.6

8.3

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.7

8.3

141

841

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

8.3

135

796

N05BA12

ATC

alprazolam; oral

1.7

8.3

142

850

UJH02

NOMESCO Finland

Anoscopy

2.4

8.2

247

A41.9

ICD-10 Finland

Sepsis, unspecified

2.7

8.2

157

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

8.2

378

R06.2

ICD-10 Finland

Wheezing

2.1

8.2

378

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.0

8.2

482

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

2.1

8.2

358

A08

ICPC

Swelling

2.2

8.2

305

R07.4

ICD-10 Finland

Chest pain, unspecified

1.5

8.2

335

2455

F25.10

ICD-10 Finland

Schizoaffective syndrome, depressive type with only concomitant bipolar and schizophrenic symptoms

4.4

8.2

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.4

8.2

N06AA12

ATC

doxepin; systemic

2.3

8.1

267

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

3.0

8.1

119

M10.0

ICD-10 Finland

Idiopathic gout

3.0

8.1

119

L40.9

ICD-10 Finland

Psoriasis, unspecified

3.3

8.1

KFA40

NOMESCO Finland

Incision of scrotum

17.3

8.1

R03AC03

ATC

terbutaline; inhalant

1.6

8.1

203

1341

K11.2

ICD-10 Finland

Sialoadenitis

2.3

8.1

249

B01AA03

ATC

warfarin; systemic

1.8

8.0

125

727

NH1BA

NOMESCO Finland

Ankle extensive X-ray examination

2.5

8.0

200

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

8.0

1168

10518

WX892

NOMESCO Finland

Monitored bed care

2.0

8.0

479

S96

ICPC

Acne

3.0

8.0

120

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

3.6

8.0

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.6

8.0

177

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

7.9

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

2.7

7.9

154

QXB05, ,

SPAT

4.5

7.9

K51.5

ICD-10 Finland

Left sided colitis

2.4

7.9

220

H36.09*E10.3

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic retinopathy

4.0

7.9

L73

ICD-10 Finland

Other follicular disorders

13.1

7.9

E10.7

ICD-10 Finland

Type 1 diabetes mellitus, With multiple complications

2.7

7.9

149

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

7.9

271

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

3.1

7.8

100

H00.00

ICD-10 Finland

Hordeolum

2.0

7.8

468

NF1AA

NOMESCO Finland

Hip X-ray examination

2.0

7.8

412

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.8

7.8

138

-, ,

ICD-10 Finland

3.2

7.8

M01AX17

ATC

nimesulide; oral

1.5

7.8

244

1691

A08AB01

ATC

orlistat; oral

8.5

7.8

SPAT1307

SPAT

Psychosocial counselling and guidance

1.7

7.8

140

848

N49.2

ICD-10 Finland

Inflammatory disorders of scrotum

10.9

7.8

R01AD08

ATC

fluticasone; nasal

1.4

7.8

460

3594

IHZ05, ,

SPAT

1.9

7.8

102

563

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

7.7

540

4334

SGC10

NOMESCO Finland

Pulp capping

1.6

7.7

176

1135

CL2S4

NOMESCO Finland

Ocular fundus photography for diabetic retinopathy screening

2.5

7.7

198

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.4

7.7

223

A04

ICPC

Weakness/tiredness general

1.5

7.7

240

1664

M01AC06

ATC

meloxicam; systemic, rectal

1.4

7.7

455

3557

Z00.8

ICD-10 Finland

Other general examinations

1.7

7.6

127

753

XX1AT

NOMESCO Finland

Other puncture with ultrasound guidance

3.7

7.6

L70

ICD-10 Finland

Acne

2.5

7.6

199

F31.8

ICD-10 Finland

Other bipolar affective disorders

2.5

7.6

199

R5599

NOMESCO Finland

Other rehabilitation service

2.6

7.6

175

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.5

7.6

187

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

2.8

7.6

129

S06.0

ICD-10 Finland

Concussion

1.6

7.6

161

1019

C09CA01

ATC

losartan; oral

1.5

7.6

254

1785

QXB10

NOMESCO Finland

Exchange of dressing for large skin wound, unspecified location

18.4

7.6

WYA10

NOMESCO Finland

Emergency care or similar visit

1.8

7.6

123

724

SPE90

NOMESCO Finland

Other partial denture

3.6

7.6

A01AB09

ATC

miconazole; local oral

1.9

7.5

100

554

F10.09

ICD-10 Finland

Alcohol intoxication UNS

2.7

7.5

141

SPAT1131

SPAT

Colonoscopy

2.8

7.5

130

F41.1

ICD-10 Finland

Generalized anxiety disorder

1.7

7.5

130

780

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.0

7.5

398

L50.9

ICD-10 Finland

Urticaria, unspecified

2.1

7.5

357

K92.1

ICD-10 Finland

Melaena

2.3

7.5

226

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.8

7.5

125

H3601, E103,

ICD-10 Finland

3.9

7.4

H36.03

ICD-10 Finland

Proliferative diabetic retinopathy

4.4

7.4

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

3.2

7.4

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.7

7.4

141

868

A10AB01

ATC

insulin (human); parenteral

2.2

7.4

265

E11.6

ICD-10 Finland

Type 2 diabetes mellitus, with other specified complications

3.5

7.4

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

2.6

7.4

154

R03AK03

ATC

[U] fenoterol and ipratropium bromide

2.6

7.4

154

RS221, ,

NOMESCO Finland

3.3

7.4

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.8

7.4

120

707

SPAT1203

SPAT

Injection therapy, other than intramuscular or subcutaneous

2.4

7.4

202

WX872

NOMESCO Finland

Intensive care

2.3

7.4

246

SPAT1281

SPAT

Other administrative function

1.8

7.4

116

677

K02.2

ICD-10 Finland

Caries of cementum

2.2

7.4

272

R4120

NOMESCO Finland

Occupational therapy

1.9

7.4

507

OSTO, ,

NOMESCO Finland

3.8

7.4

P98

ICPC

Psychosis NOS/other

4.0

7.4

R4110, ,

SPAT

1.6

7.3

165

1060

Z01.2

ICD-10 Finland

Dental examination

1.3

7.3

775

6606

XCK00

NOMESCO Finland

Perimetry

2.2

7.3

286

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

3.6

7.3

ZXD20

NOMESCO Finland

Day surgery

1.6

7.3

173

1126

7062A

ICD-9 Finland

Diseases of sebaceous glands, Sebaceous cyst[CYSTA SEBACEA (ATHEROMA)]

+∞

7.3

L93.2

ICD-10 Finland

Other local lupus erythematosus

+∞

7.3

L04AC05

ATC

ustekinumab; parenteral

6.9

7.3

N06AG02

ATC

moclobemide; oral

2.2

7.3

267

TK800

NOMESCO Finland

Hemodialysis

3.2

7.3

R31

ICD-10 Finland

Unspecified haematuria

1.9

7.3

495

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

7.3

618

5101

SPAT1099

SPAT

Measurement of blood pressure with Doppler ultrasound device

3.3

7.3

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

3.3

7.3

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.6

7.2

150

S03CA04

ATC

hydrocortisone and antiinfectives; ophthalmic, otic

2.6

7.2

150

256, ,

Kela drug reimbursment

15.8

7.2

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.0

7.2

355

R03DC03

ATC

montelukast; oral

1.5

7.2

260

1855

K07

ICPC

Swollen ankles/oedema

2.5

7.2

186

E0001A1, ,

ATC

2.5

7.2

174

SPF10

NOMESCO Finland

Demanding reparation of dental prosthesis

4.5

7.2

C10AX09

ATC

ezetimibe; oral

1.6

7.2

172

1123

P18

ICPC

Medication abuse

4.0

7.2

R61

ICD-10 Finland

Hyperhidrosis

4.0

7.2

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.8

7.2

106

608

C07AB02

ATC

metoprolol; systemic

1.6

7.2

166

1075

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.3

7.2

224

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

7.2

225

1561

R03BA02

ATC

budesonide; inhalant

1.5

7.1

267

1918

JA1AE

NOMESCO Finland

Ultrasound examination of groin and abdominal wall

3.2

7.1

S22.3

ICD-10 Finland

Fracture of rib

1.9

7.1

506

R4180, ,

SPAT

3.8

7.1

H62.0*A46

ICD-10 Finland

Otitis externa in erysipelas

4.1

7.1

V03AE01

ATC

polystyrene sulfonate; oral

5.6

7.1

QXA05

NOMESCO Finland

Skin division, unspecified location

8.8

7.0

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

2.8

7.0

129

H60.1

ICD-10 Finland

Cellulitis of external ear

3.1

7.0

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

3.1

7.0

JN2CG

NOMESCO Finland

Extensive MRI examination of lower part of abdoment with high intensity magnet

2.8

7.0

118

WXQ27

NOMESCO Finland

UVB narrow spectrum light therapy

3.5

7.0

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

7.0

L09

ICPC

Arm symptom/complaint

1.9

7.0

451

N30.9

ICD-10 Finland

Cystitis, unspecified

1.8

7.0

553

F05.9

ICD-10 Finland

Delirium, unspecified

3.9

7.0

L04AA01

ATC

[U] ciclosporin

3.9

7.0

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.3

7.0

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.6

7.0

147

RD211, ,

NOMESCO Finland

2.2

7.0

272

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

7.0

173

1139

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

3.7

6.9

R4180

NOMESCO Finland

Podiatric therapy

3.7

6.9

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.5

6.9

216

1496

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.4

6.9

502

4040

L72.2

ICD-10 Finland

Steatocystoma multiplex

13.8

6.9

Z36.3

ICD-10 Finland

Antenatal screening for malformations using ultrasound and other physical methods

0.7

6.9

301

3967

A77

ICPC

Viral disease other/NOS

2.0

6.9

348

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

2.2

6.9

254

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.7

6.8

131

808

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.3

6.8

235

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.0

6.8

349

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

6.8

156

1007

N06AX22

ATC

agomelatine; oral

2.3

6.8

229

SPAT1234

SPAT

Support of social functional capacity

2.2

6.8

249

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

6.1

6.8

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

4.3

6.8

F25.20

ICD-10 Finland

Schizoaffective syndrome, mixed type with only concomitant bipolar and schizophrenic symptoms

4.3

6.8

-34

ICPC

Blood test

2.4

6.8

192

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.4

6.8

192

A10BJ01

ATC

exenatide; parenteral

3.9

6.7

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.8

6.7

106

620

L08

ICD-10 Finland

Other local infections of skin and subcutaneous tissue

2.5

6.7

156

R52.0

ICD-10 Finland

Acute pain

2.1

6.7

317

F02

ICPC

Red eye

2.0

6.7

338

W10

ICD-10 Finland

Fall on and from stairs and steps

1.9

6.7

394

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.1

6.7

311

N06AB05

ATC

paroxetine; oral

1.8

6.7

532

L03.8

ICD-10 Finland

Cellulitis of other sites

5.5

6.6

N18.8

ICD-10 Finland

Other chronic renal failure

3.6

6.6

-56

ICPC

Dressing/pressure/compress/tamponade

3.2

6.6

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.0

6.6

368

188

Kela drug reimbursment

Psychosis requiring demanding treatment

3.4

6.6

L01

ICPC

Neck symptom/complaint

1.4

6.6

266

1940

27799

ICD-8 Finland

Obesity not specified as of endocrine origin

8.7

6.6

D06BX01

ATC

metronidazole; topical

1.6

6.5

139

881

R01AD09

ATC

mometasone; nasal

1.3

6.5

745

6381

M84.3

ICD-10 Finland

Stress fracture, not elsewhere classified

2.9

6.5

106

L04AB02

ATC

infliximab; parenteral

3.8

6.5

QBE40

NOMESCO Finland

Repair of anomaly or lesion after disease of skin of trunk

10.1

6.5

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

10.1

6.5

C03AA03

ATC

hydrochlorothiazide; oral

2.0

6.5

334

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

6.5

155

1010

S92.5

ICD-10 Finland

Fracture of other toe

2.2

6.5

260

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

6.5

109

649

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

6.5

221

Z37.0

ICD-10 Finland

Single live birth

0.6

6.5

1426

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

6.5

335

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

6.5

356

QDG20

NOMESCO Finland

Operation for chronic ulcer or fistula of skin of lower limb

6.2

6.5

L04AB05

ATC

certolizumab pegol; parenteral

5.3

6.5

ZYC03

NOMESCO Finland

Remote contact, text-based

5.7

6.5

E10.1

ICD-10 Finland

Type 1 diabetes mellitus, With ketoacidosis

3.2

6.4

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

3.2

6.4

EBA10

NOMESCO Finland

Operative extraction of tooth

1.4

6.4

265

1937

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.5

6.4

Z01.9

ICD-10 Finland

Special examination, unspecified

1.9

6.4

442

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.0

6.4

357

L70.2

ICD-10 Finland

Acne varioliformis

7.4

6.4

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.3

6.4

191

H66.9

ICD-10 Finland

Otitis media, unspecified

1.7

6.4

126

785

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.7

6.3

111

669

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

6.3

563

A10BB01

ATC

glibenclamide; oral

3.6

6.3

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

6.3

128

802

J01CE08

ATC

benzathine benzylpenicillin; parenteral

6.0

6.3

N08.39*E10.2

ICD-10 Finland

Insulin-dependent diabetes mellitus - Diabetic nephropathy

5.5

6.3

XF600

NOMESCO Finland

Bloodpressure measurement

1.9

6.3

395

L84

ICPC

Back syndrome without radiat pain

1.9

6.3

431

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

9.3

6.3

K76.9

ICD-10 Finland

Liver disease, unspecified

3.4

6.3

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

6.3

453

H00.1

ICD-10 Finland

Chalazion

2.0

6.3

325

WVA20

NOMESCO Finland

Medicine administration

2.3

6.3

186

S83.0

ICD-10 Finland

Dislocation of patella

2.3

6.3

205

F31

ICD-10 Finland

Bipolar affective disorder

2.8

6.3

103

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.2

6.3

244

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

6.3

149

971

K03.66

ICD-10 Finland

Tooth plaque

1.7

6.2

110

664

E86

ICD-10 Finland

Volume depletion

3.0

6.2

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

6.2

135

860

L18

ICPC

Muscle pain

2.0

6.2

326

K59.0

ICD-10 Finland

Constipation

2.0

6.2

340

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.8

6.2

499

F20.04

ICD-10 Finland

Paranoid schizophrenia with partial recurrence

3.7

6.2

A03FA01

ATC

metoclopramide; systemic, rectal

1.4

6.2

289

2160

M02AA10

ATC

ketoprofen; topical

1.5

6.2

181

1236

D73

ICPC

Gastroenteritis presumed infection

1.9

6.2

448

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.8

6.2

537

F42.2

ICD-10 Finland

Mixed obsessional thoughts and acts

3.1

6.2

SPAT1294

SPAT

Other function in accordance with health social work nomenclature

2.9

6.2

F25.11

ICD-10 Finland

Schizoaffective syndrome, depressive type with prolonged schizophrenic than bipolar symptoms

6.3

6.2

I20.00

ICD-10 Finland

Unstable angina

3.2

6.2

I70.9

ICD-10 Finland

Generalized and unspecified atherosclerosis

5.4

6.2

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

6.2

134

855

WX730

NOMESCO Finland

Conventional respirator

3.4

6.1

N05AL01

ATC

sulpiride; systemic

3.3

6.1

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

3.3

6.1

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.5

6.1

203

1422

L30.8

ICD-10 Finland

Other specified dermatitis

2.3

6.1

207

R08

ICPC

Nose symptom/complaint other

2.0

6.1

321

EKA10

NOMESCO Finland

iopsy of buccal mucosa

2.8

6.1

110

K61.1

ICD-10 Finland

Rectal abscess

7.7

6.1

S56

ICPC

Skin, Dressing/pressure/compress/tamponade

7.7

6.1

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.9

6.1

371

R51

ICD-10 Finland

Headache

1.7

6.1

106

638

E000007, ,

ATC

1.8

6.1

480

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

6.1

254

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

6.1

105

R03AC13

ATC

formoterol; inhalant

2.0

6.1

295

F42.9

ICD-10 Finland

Obsessive-compulsive disorder, unspecified

3.6

6.0

H29

ICPC

Ear symptom/complaint other

1.6

6.0

152

1004

W19

ICD-10 Finland

Unspecified fall

1.6

6.0

122

764

H36.00

ICD-10 Finland

Diabetic background retinopathy

3.2

6.0

H01.0

ICD-10 Finland

Blepharitis

1.6

6.0

120

749

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

5.2

6.0

NHQ40

NOMESCO Finland

Amputation of toe

5.2

6.0

D09

ICPC

Nausea

1.8

6.0

534

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3007853) Bacteria identified in Skin by Aerobe culture

582

1572

5.20

207.79

2.4

1.6

—

(3042936) Bacteria identified in Isolate by Culture

583

1733

4.68

181.78

2.8

1.9

—

(3001604) Monocytes [#/volume] in Blood

1175

7278

3.20

98.33

10.0

6.4

0.62

0.55

e9/l

22.24

1073

6374

(3006315) Basophils [#/volume] in Blood

1176

7289

3.20

98.27

10.0

6.4

0.05

0.04

e9/l

7.50

1078

6382

(3013115) Eosinophils [#/volume] in Blood

1194

7539

3.18

95.02

10.2

6.6

0.20

0.18

e9/l

3.61

1104

6708

(3019198) Lymphocytes [#/volume] in Blood

1180

7481

3.09

91.60

10.1

6.4

2.22

1.98

e9/l

12.97

1098

6726

(3019069) Monocytes/Leukocytes in Blood

1086

6649

2.90

88.68

9.9

6.6

7.90

8.43

11.63

1062

6295

(3006504) Eosinophils/Leukocytes in Blood

1082

6639

2.87

87.48

9.8

6.5

2.60

2.79

2.70

1054

6273

(3022096) Basophils/Leukocytes in Blood

1078

6637

2.84

85.93

9.9

6.5

0.67

0.68

0.46

1052

6261

(3013650) Neutrophils [#/volume] in Blood by Automated count

1219

8055

3.03

84.04

13.6

9.4

4.79

4.00

e9/l

27.90

1129

7075

(3018010) Neutrophils/Leukocytes in Blood

1086

6786

2.80

82.74

9.6

6.3

58.24

56.50

6.68

1066

6536

(3024561) Albumin [Mass/volume] in Serum or Plasma

911

5254

2.66

80.94

6.7

4.8

35.61

36.99

g/l

11.00

879

4981

(3002030) Lymphocytes/Leukocytes in Blood

1093

6899

2.77

80.78

9.9

6.4

28.14

29.22

3.37

1067

6597

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

213

530

4.47

78.89

1.7

1.5

0.05

0.19

iu/ml

0.50

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1060

6695

2.67

76.36

6.1

6.0

9.55

10.55

umol/l

1.72

1012

6383

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1379

10122

3.35

71.91

11.1

7.5

82.31

74.75

u/l

5.67

1344

9661

(3023368) Bacteria identified in Blood by Culture

579

2914

2.53

64.94

5.0

4.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1111

7541

2.48

62.88

6.2

4.8

6.86

6.41

mmol/l

7.80

1051

6978

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

724

4104

2.37

61.63

3.7

2.6

52.52

58.97

u/l

1.81

675

3844

(3032080) INR in Blood by Coagulation assay

820

4960

2.31

59.30

10.5

8.9

1.13

1.12

inr

0.15

715

4099

(3037522) Nuclear Ab [Titer] in Serum

473

2244

2.56

59.26

1.5

1.4

479.63

540.36

titre

0.34

109

450

(3020682) Albumin/Creatinine [Ratio] in Urine

621

3414

2.32

55.36

5.0

4.2

13.64

8.52

mg/mmol

1.01

432

2184

(3002179) Metamyelocytes/Leukocytes in Blood

294

1132

2.95

55.04

5.8

4.6

0.37

0.66

1.89

126

307

(3009508) Creatinine [Moles/volume] in Urine

703

4100

2.26

54.10

4.2

3.5

7.86

8.24

mmol/l

1.16

620

3601

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

1339

10230

2.73

53.88

6.3

4.0

14.95

9.57

mm/h

27.42

1292

9687

(3012516) Albumin [Mass/volume] in Urine

610

3361

2.30

53.77

4.2

3.6

73.80

48.08

mg/l

1.42

438

2198

(3017181) Myelocytes/Leukocytes in Blood

297

1185

2.84

51.86

6.0

4.7

0.51

0.98

3.47

125

329

(3023520) Reticulocytes [#/volume] in Blood

228

790

3.19

51.12

4.0

2.9

82.17

72.38

e9/l

3.39

195

555

(3048689) Calprotectin [Mass/mass] in Stool

454

2259

2.40

50.10

3.7

2.6

137.90

109.65

ug/g

0.85

382

1821

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

814

5226

2.11

47.11

2.3

1.9

96.23

97.13

pmol/l

0.23

507

2916

(3021440) Promyelocytes/Leukocytes in Blood

280

1136

2.77

47.06

6.2

4.8

0.03

0.12

2.87

107

278

(3027945) Reticulocytes/Erythrocytes in Blood

272

1096

2.78

46.27

3.9

2.9

1.92

1.74

2.34

261

989

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

876

5824

2.09

45.68

9.0

6.6

1.21

mmol/l

0.35

774

5064

(3025159) Blasts/Leukocytes in Blood

280

1161

2.70

44.97

6.7

5.1

0.00

0.43

0.79

106

261

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

784

5108

2.03

42.03

3.7

3.2

31.92

29.93

u/l

0.28

752

4861

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

912

6318

2.01

40.57

3.3

2.4

69.14

73.84

nmol/l

6.23

861

5936

(3017143) Hepatitis C virus Ab [Presence] in Serum

446

2393

2.19

39.84

1.8

1.6

—

(3021960) Folate [Moles/volume] in Serum or Plasma

548

3206

2.07

38.86

1.9

1.6

19.19

20.10

nmol/l

0.63

489

2847

(3022948) Iron [Moles/volume] in Serum or Plasma

394

2030

2.24

38.79

3.2

2.4

12.35

14.67

umol/l

7.22

370

1910

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

210

820

2.79

37.54

1.9

1.6

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

7.87

37.53

2.2

2.6

8.81

9.89

mg/l

0.55

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

770

5130

1.95

37.28

8.1

6.2

1.21

mmol/l

0.48

735

4798

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

249

1078

2.55

36.16

2.5

2.4

0.22

g/l

0.09

239

1020

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

563

3400

2.00

36.00

3.1

2.2

2.90

2.59

mg/l

2.26

512

2987

(3023420) DNA double strand Ab [Units/volume] in Serum

172

641

2.88

33.43

1.7

2.2

2.93

7.70

iu/ml

3.01

153

(40760892) CBC W Ordered Manual Differential panel - Blood

599

3780

1.92

33.06

7.7

4.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

346

1804

2.17

32.44

2.0

1.9

—

(3009343) pH of Capillary blood

174

667

2.80

32.05

3.6

3.5

7.42

7.41

1.01

155

564

(3021589) Normoblasts [#/volume] in Blood

889

6420

1.85

31.62

16.0

9.8

0.00

e9/l

0.46

769

5271

(3000850) Epithelial cells [#/volume] in Urine

461

2701

1.99

31.38

3.6

2.5

7.17

7.44

e6/l

0.17

436

2460

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1476

12736

2.67

31.12

8.0

4.9

40.54

37.66

mmol/mol

18.73

1419

12223

(3004789) Transferrin [Mass/volume] in Serum or Plasma

349

1855

2.12

30.99

3.3

2.4

2.38

2.41

g/l

0.53

327

1728

(3026008) Bacteria identified in Urine by Culture

569

3591

1.90

30.95

3.1

2.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

312

1593

2.19

30.69

1.8

1.7

1167.43

1179.18

nmol/l

0.08

246

1252

(3021879) Hepatitis B virus core Ab [Presence] in Serum

317

1633

2.17

30.47

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

156

588

2.83

29.60

3.3

3.4

1.82

1.50

mmol/l

0.41

120

415

(3018418) pH of Serum or Plasma

547

3461

1.87

29.16

4.8

3.8

7.40

0.13

393

2415

(3023103) Potassium [Moles/volume] in Serum or Plasma

1554

13864

3.56

29.10

23.3

12.8

3.97

3.93

mmol/l

11.26

1544

13561

(3019550) Sodium [Moles/volume] in Serum or Plasma

1551

13827

3.48

28.97

23.0

12.7

139.20

139.63

mmol/l

10.88

1539

13549

(3002582) Erythrocytes [#/volume] in Urine

614

4040

1.83

28.79

3.9

3.0

30.05

74.71

e6/l

1.14

494

3005

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

8.08

28.20

2.2

2.0

139.56

162.11

au/ml

—

(3035350) Ketones [Presence] in Urine by Test strip

1001

7644

1.80

28.16

4.6

3.4

7.25

7.13

estimate

0.01

259

1607

(3031040) Bacteria [#/volume] in Urine by Automated count

1140

9078

1.85

27.64

5.5

4.0

511.71

1207.42

e6/l

0.49

110

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

411

2404

1.95

27.60

2.0

1.6

13960515.50

48466682.25

pmol/l

1.03

351

2119

(3009261) Glucose [Presence] in Urine by Test strip

1000

7671

1.78

27.31

4.6

3.4

0.03

0.21

estimate

0.44

230

1529

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

312

1664

2.08

27.12

3.5

2.5

20.22

24.48

6.82

294

1560

(40768443) Skin Pathology biopsy report

134

489

2.90

26.95

1.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

987

7574

1.77

26.59

4.5

3.3

0.00

estimate

0.50

257

1604

(3035715) Granulocytes [#/volume] in Blood

244

3.67

26.12

3.8

3.9

4.67

4.03

e9/l

1.99

244

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

6.61

26.07

3.7

2.7

185.58

76.55

au/ml

—

(3017732) Neutrophils [#/volume] in Blood

329

1813

2.02

26.06

3.7

3.1

4.87

4.80

e9/l

0.06

296

1647

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

6.14

26.00

4.3

3.5

6.99

8.12

mg/l

0.72

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1567

14194

3.65

25.65

23.8

12.2

19.44

20.99

mg/l

1.36

1463

11421

(3012095) Magnesium [Moles/volume] in Serum or Plasma

345

1959

1.97

24.98

3.3

3.6

0.79

0.82

mmol/l

5.54

330

1878

(3003458) Phosphate [Moles/volume] in Serum or Plasma

278

1466

2.08

24.73

8.4

6.3

1.08

1.04

mmol/l

1.36

261

1376

(3026493) Urate [Moles/volume] in Serum or Plasma

509

3284

1.80

24.65

2.7

2.5

347.31

322.26

umol/l

7.16

462

3005

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

539

3543

1.78

24.47

2.2

2.1

185.54

177.54

u/l

0.09

518

3384

(3022145) Colonoscopy Study observation

279

1479

2.07

24.46

1.5

1.4

—

(3018095) Leukocytes [#/volume] in Urine

701

4969

1.72

24.32

4.7

3.5

82.99

61.74

e6/l

0.36

522

3276

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

413

2509

1.87

24.28

2.6

3.0

1002.39

709.31

ng/l

0.68

337

2048

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

594

4048

1.74

23.57

1.5

1.3

1.69

1.59

u/ml

0.06

185

1186

(3000494) Fungus identified in Specimen by Culture

303

1680

1.99

23.36

1.7

1.4

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1350

11573

1.97

23.29

5.7

4.5

14.62

14.40

pmol/l

3.01

1281

10900

(3015171) Extractable nuclear Ab [Units/volume] in Serum

152

638

2.52

23.20

1.3

0.30

1.43

u/ml

1.21

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

233

1177

2.14

23.11

2.7

4.6

209.48

238.71

u/l

3.34

217

1129

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

624

4338

1.71

22.86

3.6

2.9

39.90

28.73

ng/l

0.75

332

2316

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

377

2266

1.86

22.74

2.4

1.8

1.54

1.41

2.43

336

2035

(3030467) Casts [#/volume] in Urine by Automated count

526

3493

1.75

22.71

3.7

2.8

0.55

0.35

e6/l

0.75

415

2479

(3003396) Base excess in Arterial blood by calculation

220

1096

2.16

22.59

9.1

9.9

1.10

0.76

mmol/l

0.59

183

904

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

251

1316

2.07

22.55

3.3

2.3

4072.46

6687.76

u/l

0.75

566

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

248

1298

2.07

22.37

1.9

1.8

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1475

13117

2.30

22.21

5.8

4.1

6.21

5.71

mmol/l

24.89

1396

12402

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

220

1113

2.13

21.67

9.2

9.9

5.24

5.09

kpa

1.27

214

1073

(3027801) Oxygen [Partial pressure] in Arterial blood

220

1113

2.13

21.67

9.2

9.8

11.33

13.08

kpa

8.59

214

1075

(3028026) IgM [Mass/volume] in Serum or Plasma

187

888

2.25

21.58

1.6

1.9

1.10

1.35

g/l

2.64

170

835

(3015377) Calcium [Moles/volume] in Serum or Plasma

605

4241

1.68

21.05

3.1

3.2

2.36

2.35

mmol/l

1.23

561

3959

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1270

10794

1.80

20.93

4.5

3.1

52.87

38.99

u/l

7.76

1219

10412

(3005719) IgG [Mass/volume] in Serum or Plasma

223

1149

2.09

20.91

2.9

10.98

10.55

g/l

0.89

211

1073

(3016502) Oxygen saturation in Arterial blood

199

982

2.17

20.86

9.1

10.6

95.90

96.13

0.35

193

954

(3019977) pH of Arterial blood

217

1110

2.10

20.73

9.5

9.9

7.41

0.18

131

608

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

499

3344

1.71

20.43

1.9

1.8

0.81

0.94

mg/l

0.67

391

2531

(3029937) Albumin [Presence] in Urine by Test strip

578

4028

1.67

20.43

5.0

3.5

0.00

0.01

estimate

1.70

246

1527

(3019060) Gas panel - Arterial blood

127

520

2.56

20.38

4.9

7.0

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

1490

13399

2.30

20.25

20.0

10.8

94.29

91.54

ml/min/173m2

5.25

1411

12128

(3020779) Urea [Moles/volume] in Serum or Plasma

187

912

2.19

20.17

10.6

8.5

9.88

7.79

mmol/l

3.23

182

878

(3036481) Cortisol [Moles/volume] in Serum or Plasma

262

1451

1.96

20.05

2.2

2.1

359.97

379.16

nmol/l

0.89

242

1366

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

276

1556

1.93

20.04

2.3

2.7

7.87

6.89

umol/l

0.24

219

1354

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1486

13363

2.26

19.95

6.9

5.3

1.76

1.78

mu/l

0.06

1419

12748

(3015736) pH of Urine

810

6173

1.62

19.87

4.1

3.0

6.17

6.20

0.44

495

3636

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

768

5797

1.61

19.46

2.5

1.8

1.66

1.38

mmol/l

11.06

682

5100

(3035933) Granulocytes/Leukocytes in Blood

322

2.93

19.33

3.9

3.6

58.54

57.62

0.36

322

(3007164) IgA [Mass/volume] in Serum or Plasma

509

3480

1.67

19.08

1.6

1.5

2.65

2.22

g/l

4.12

347

2336

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1528

13953

2.51

18.93

6.2

4.3

4.54

4.74

mmol/l

14.48

1469

13420

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

214

1127

2.03

18.82

3.7

2.8

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

856

6666

1.60

18.79

3.0

2.7

—

estimate

—

(40758558) Short blood count panel - Blood

578

4095

1.64

18.78

7.3

5.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

1599

14969

4.48

18.72

27.4

14.2

72.74

71.14

umol/l

0.82

1594

14820

(3026782) Osmolality of Urine

368

2323

1.75

18.39

3.2

2.6

510.13

531.96

mosm/kgh2o

1.00

338

2057

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1460

13124

2.07

18.26

5.1

3.7

1.56

1.26

mmol/l

35.87

1391

12507

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

231

1265

1.96

18.16

2.0

1.8

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

769

5887

1.58

17.81

4.4

3.1

0.02

estimate

0.15

225

1348

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

551

3901

1.62

17.73

1.9

1.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1595

14956

4.01

17.59

19.1

10.1

28.56

26.34

u/l

2.54

1583

14648

(3007566) Smooth muscle Ab [Titer] in Serum

104

420

2.58

17.16

1.2

1.3

81.33

103.41

titre

0.67

(3006184) Hemoglobin [Mass/volume] in Capillary blood

262

2.95

16.32

2.7

2.2

134.61

133.49

g/l

0.12

218

(44816559) Phosphatidylethanol [Mass/volume] in Blood

161

805

2.11

16.21

2.1

1.7

0.30

0.31

mg/l

0.02

382

(3002256) Pathology report gross observation

283

1713

1.79

16.15

1.3

1.2

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

636

4762

1.55

15.61

2.2

2.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

126

581

2.27

15.52

2.2

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1522

14043

2.25

15.47

6.2

4.7

2.71

2.83

mmol/l

7.09

1456

13451

(3001122) Ferritin [Mass/volume] in Serum or Plasma

976

8030

1.54

15.41

4.0

3.2

103.11

86.12

ug/l

2.41

933

7670

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

437

3026

1.61

14.93

1.4

1.3

24.19

25.97

iu/ml

0.11

109

890

(3030981) Hyaline casts [#/volume] in Urine by Automated count

174

923

1.99

14.89

2.7

2.4

0.24

0.32

e6/l

0.34

164

878

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

317

2.67

14.78

2.5

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1509

13916

2.13

14.71

5.5

4.2

1.29

1.47

mmol/l

62.45

1444

13325

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

104

452

2.39

14.68

1.2

—

(3022313) Gas panel - Capillary blood

105

464

2.35

14.28

3.6

—

(3037121) Protein [Mass/volume] in Urine

422

2.41

14.12

4.0

3.9

315.28

284.71

mg/l

0.13

190

(3026389) Candida sp identified in Specimen by Organism specific culture

190

3.13

14.12

1.6

1.3

—

(40768797) Stomach Pathology biopsy report

284

1793

1.71

13.82

1.2

—

(3033658) Prothrombin time (PT) actual/Normal

466

3329

1.56

13.74

4.7

3.7

95.63

95.17

0.16

449

3259

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

128

3.59

13.68

1.3

1.5

1.92

1.44

nmol/l

1.66

117

(3047181) Lactate [Moles/volume] in Blood

324

2.58

13.65

6.4

8.4

1.30

1.20

mmol/l

0.66

279

(40768804) Tissue Pathology biopsy report

708

5537

1.49

13.60

2.1

2.0

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

164

881

1.96

13.51

4.7

3.3

1.22

1.23

mmol/l

0.64

139

756

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

381

2.44

13.47

1.2

29.34

40.12

u/ml

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

328

2166

1.64

13.41

4.1

3.2

600.94

491.29

ng/l

0.12

184

1324

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

145

3.38

13.33

1.1

1.2

—

31.40

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

126

619

2.12

13.26

3.1

2.8

140.55

116.60

ng/l

0.30

113

546

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

322

2124

1.64

13.20

2.8

2.6

1.27

1.23

e6/l

0.05

170

1037

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

104

475

2.27

13.11

1.5

2.0

0.24

0.23

g/l

0.50

449

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

123

607

2.11

12.80

1.7

1.6

—

(3019150) Specific gravity of Urine by Refractometry

463

3351

1.53

12.70

4.8

3.3

1.02

1.94

kg/l

0.80

331

2184

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

396

2773

1.57

12.59

1.4

1.3

9.61

9.55

u/ml

0.01

165

1188

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

285

2.60

12.42

1.2

1.3

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

105

495

2.20

12.27

1.6

2.0

1.23

1.18

g/l

0.85

100

469

(3012501) Base excess in Blood by calculation

224

2.79

12.17

5.1

3.3

2.26

2.30

mmol/l

0.04

132

(3048929) Epstein Barr virus Ab [Presence] in Serum

138

726

1.98

12.06

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

4.46

11.93

2.0

3.2

130.00

141.38

umol/l

0.08

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

164

926

1.86

11.60

1.6

1.4

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

146

795

1.92

11.54

4.9

4.1

106.79

77.17

ng/l

1.69

135

720

(3044640) Blood type and Crossmatch panel - Blood

579

4458

1.46

11.50

2.6

2.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

384

2.31

11.45

1.4

1.3

—

(1616796) Gas panel - Central venous blood

244

2.65

11.37

6.2

3.0

—

(3028707) Methadone [Presence] in Urine by Screen method

104

508

2.12

11.13

3.0

2.8

—

(40761535) Cells panel - Urine sediment

150

835

1.88

11.09

4.2

3.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

450

2.18

10.99

1.2

1.3

5.38

8.47

u/ml

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

448

3305

1.49

10.95

2.4

2.1

—

(3025941) Bacteria identified in Stool by Culture

159

906

1.84

10.92

1.3

1.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

362

2.30

10.78

1.9

2.0

2.91

1.86

ug/l

0.37

326

(3008898) HLA-B27 [Presence]

138

761

1.89

10.50

1.1

—

(3052851) Hemolysis interference index of Serum or Plasma

310

2.38

10.43

2.7

2.8

1.57

2.15

index

0.47

166

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

315

2177

1.55

10.40

2.4

2.5

2.45

2.42

mmol/l

3.16

287

1965

(3012544) pH of Venous blood

178

1068

1.75

10.27

5.8

4.0

7.37

7.38

0.34

110

597

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

386

2.21

10.06

2.2

1.8

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

176

1060

1.74

10.02

5.7

3.9

5.91

5.80

kpa

0.64

171

1031

(3041096) Erythrocytes [Presence] in Urine by Automated

573

4492

1.42

9.99

3.7

2.7

0.00

0.07

estimate

0.98

221

1328

(3023183) Ammonium ion [Moles/volume] in Plasma

226

2.58

9.85

2.4

3.1

32.25

31.64

umol/l

0.08

212

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

210

2.63

9.70

1.7

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

310

2.31

9.54

2.5

2.9

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

103

3.35

9.47

1.1

1298.81

1402.24

miu/ml

0.22

103

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

540

4222

1.42

9.44

1.9

1.7

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

263

1781

1.57

9.44

2.0

2.2

29.70

29.30

0.40

257

1737

(3011288) Drugs identified in Urine by Screen method Nominal

145

844

1.79

9.28

3.3

2.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

194

1225

1.66

9.27

6.9

5.1

—

(3000991) Gas panel - Venous blood

156

932

1.75

9.13

11.1

9.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

182

2.69

9.08

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

107

3.22

8.93

2.3

3.5

—

(40761536) Microorganisms panel - Urine sediment

193

1237

1.64

8.69

4.9

3.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

310

2.25

8.68

4.7

6.2

286.00

326.19

iu/ml

0.10

(36660697) Celiac disease serology panel - Serum

205

1334

1.61

8.68

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

433

2.04

8.54

2.2

1.9

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

374

2.11

8.41

1.4

297.30

303.66

ug/g

0.09

207

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

355

2.14

8.35

1.3

1.4

23.42

21.64

u/l

0.23

301

(1001926) Buprenorphine [Presence] in Urine by Screen method

151

929

1.69

7.95

2.5

2.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

257

2.30

7.94

3.6

4.5

0.33

0.36

iu/ml

0.31

123

(3002032) Base excess in Venous blood by calculation

163

1026

1.65

7.87

6.0

3.9

1.96

1.74

mmol/l

0.30

141

889

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

149

2.73

7.86

1.3

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

118

682

1.79

7.75

1.8

1.3

—

(3045414) Leukocytes [Presence] in Urine

187

1226

1.59

7.66

1.9

0.04

0.03

estimate

0.14

296

(4198724) Urine methamphetamine measurement

102

3.08

7.60

2.5

2.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

153

2.65

7.49

1.4

—

(3042631) Mycobacterium sp identified in Specimen

114

2.93

7.45

2.0

3.0

—

(3019225) pH of Specimen

156

986

1.64

7.41

6.1

3.5

7.35

7.34

0.18

133

730

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

227

2.33

7.39

2.6

2.5

180.64

88.99

ug/min

0.68

141

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

168

1083

1.61

7.38

2.8

3.5

4.44

4.61

pmol/l

1.36

148

984

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

522

1.87

7.36

1.4

1.3

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

274

1975

1.47

7.21

3.0

2.7

5.51

3.45

e6/l

1.42

123

901

(3025468) Yersinia sp identified in Specimen by Organism specific culture

145

2.66

7.16

1.4

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

121

724

1.73

7.07

2.2

2.1

6.04

7.90

ug/l

0.59

105

657

(3024980) IgG subclass 4 [Mass/volume] in Serum

284

2.16

7.04

1.3

1.7

0.41

0.74

g/l

3.12

225

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

338

2.06

7.04

1.2

1.3

—

3.90

—

(4062490) Immunoglobulin typing, IgG

170

2.51

7.04

1.3

1.4

—

(3016879) Cocaine [Presence] in Urine

166

1082

1.59

6.97

2.6

2.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

153

2.59

6.96

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

115

682

1.74

6.94

1.3

1.4

11.71

9.54

u/l

0.99

568

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

396

1.96

6.91

1.7

2.3

1.73

1.40

g/l

2.76

354

(3016650) Hepatitis A virus Ab [Presence] in Serum

287

2.13

6.87

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

195

1326

1.53

6.80

3.6

2.4

35.42

76.57

u/l

0.58

173

1121

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

230

2.26

6.75

1.8

3.3

1.35

1.98

ratio

1.04

128

(3014148) Varicella zoster virus Ab [Titer] in Serum

303

2.09

6.72

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

311

2.07

6.66

1.3

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

169

2.46

6.63

1.3

1.4

3.48

2.99

g/l

0.83

120

(3024139) IgG subclass 3 [Mass/volume] in Serum

169

2.46

6.63

1.3

1.4

0.40

0.36

g/l

0.45

120

(3027135) IgG subclass 1 [Mass/volume] in Serum

169

2.46

6.63

1.3

1.4

6.46

6.27

g/l

0.20

121

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

208

2.30

6.51

1.3

1.5

—

10.40

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

147

2.55

6.46

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

147

2.55

6.46

1.4

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

274

2.12

6.46

1.0

1.1

109.67

1965.34

iu/ml

0.49

(3047352) Trisomy 18 risk [Likelihood] in Fetus

804

0.42

6.28

1.4

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

407

3218

1.35

6.19

2.4

2.2

—

(3005033) Fetal Nuchal fold Thickness US

791

0.43

6.03

1.4

1.5

1.18

1.27

0.50

574

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

262

2.10

6.00

2.4

3.5

37.98

38.69

mg/l

0.03

221

(3034860) Kappa light chains.free [Mass/volume] in Serum

262

2.10

6.00

2.4

3.5

49.50

59.24

mg/l

0.16

222

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

166

2383

0.66

5.91

1.6

1.8

3.94

3.46

ratio

3.11

124

1768

(3043238) Trisomy 21 risk [Likelihood] in Fetus

823

0.45

5.87

1.7

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

104

631

1.69

5.81

1.5

2.2

37.87

39.55

u/l

0.37

583

(3006653) Thiamine [Moles/volume] in Blood

3.03

5.81

1.5

1.6

147.51

139.74

nmol/l

0.26

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

965

0.49

5.80

1.3

1.5

1.22

1.16

ratio

0.13

588

(3000012) Reticulocyte production index

114

2.66

5.75

1.5

2.1

0.93

0.95

0.04

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

275

2.03

5.66

1.1

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

410

1.84

5.65

4.5

3.4

25.09

25.00

mmol/l

0.08

392

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

956

0.50

5.64

1.3

1.5

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

121

2.59

5.64

1.9

2.2

33.55

32.55

0.56

121

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

127

2.55

5.63

1.4

1.3

—

(3003327) Ova and parasites identified in Stool by Light microscopy

103

629

1.68

5.63

1.8

1.7

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

967

0.50

5.61

1.3

1.5

0.87

0.94

ratio

0.56

590

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

967

0.50

5.61

1.3

1.5

1.35

1.16

ratio

0.36

592

(3020911) Cortisol [Moles/time] in 24 hour Urine

3.42

5.59

1.6

1.3

99.12

84.22

nmol/24h

0.29

(21494755) Public health laboratory ask at order entry panel

147

2135

0.66

5.53

1.2

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

193

1371

1.46

5.44

4.6

3.9

29.93

31.55

1.30

153

999

(3028300) Cannabinoids [Presence] in Urine

169

1170

1.50

5.42

2.6

2.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

193

1373

1.46

5.40

1.4

21.65

23.28

iu/l

0.35

165

1171

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

130

2.49

5.38

1.4

1.5

—

(3027008) Opiates [Presence] in Urine

168

1164

1.49

5.37

2.6

2.1

—

(3000492) Spirometry study

227

1668

1.42

5.34

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

170

1185

1.49

5.28

1.5

1.3

217.91

288.10

u/ml

0.36

160

1106

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

255

2.03

5.27

2.7

3.5

474.80

1854.40

u/ml

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

140

937

1.54

5.26

2.9

4.5

8.11

19.32

ug/l

0.79

118

719

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

126

2.49

5.22

1.4

1.3

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

123

1829

0.65

5.17

1.4

1.6

3.46

mmol/l

0.02

1231

(3017446) Testosterone [Moles/volume] in Serum or Plasma

161

1118

1.49

5.09

2.3

9.41

12.75

nmol/l

4.81

143

1043

(3000764) Benzodiazepines [Presence] in Urine

166

1160

1.48

5.09

2.6

2.1

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

10.05

5.03

3.0

1.8

2.62

2.88

mg/l

—

(3027944) Amphetamines [Presence] in Urine

165

1155

1.48

5.02

2.6

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

199

2.14

5.00

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

3.18

4.77

1.2

1.1

—

40.00

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

613

1.62

4.68

1.9

1.5

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1037

0.56

4.67

1.5

59.42

59.87

ug/l

0.02

875

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

134

913

1.51

4.66

3.1

1.8

—

(3024731) MCV [Entitic mean volume] in Red Blood Cells

1609

15773

2.49

4.64

36.3

18.6

90.93

90.23

7.25

1604

15666

(3017704) Immunofixation for Urine

3.36

4.61

1.3

1.8

—

(1002224) Polysomnography panel

136

932

1.50

4.60

1.1

—

(3035941) MCH [Entitic mass]

1609

15775

2.48

4.60

36.3

18.6

30.16

30.14

0.16

1604

15668

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

1609

15776

2.48

4.58

37.0

19.0

40.96

41.02

0.07

1604

15661

(3026361) Erythrocytes [#/volume] in Blood

1609

15776

2.48

4.58

36.4

18.6

4.55

e12/l

0.17

1599

15518

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

427

3527

1.29

4.57

2.4

2.3

—

(3006571) Granulocytes/Leukocytes in Synovial fluid

122

2.40

4.57

1.3

1.7

39.93

54.80

0.84

(3000475) Leukocytes [#/volume] in Synovial fluid

277

1.91

4.53

1.6

1.7

8329.39

10333.53

e6/l

0.24

210

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

503

0.39

4.53

1.0

1.3

—

(3007461) Platelets [#/volume] in Blood

1608

15765

2.42

4.52

36.6

18.7

277.38

260.05

e9/l

21.14

1600

15532

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

201

2.07

4.51

1.2

—

14.36

—

(3024354) Oxygen [Partial pressure] in Venous blood

131

895

1.50

4.50

4.6

3.2

4.81

4.64

kpa

0.42

126

870

(3010813) Leukocytes [#/volume] in Blood

1609

15780

2.46

4.50

36.5

18.7

7.91

6.72

e9/l

61.01

1597

15515

(3003329) Lymphocytes/Leukocytes in Synovial fluid

2.67

4.49

1.3

1.5

34.87

35.64

0.02

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

3.29

4.47

1.1

1.2

—

(3000963) Hemoglobin [Mass/volume] in Blood

1609

15784

2.44

4.43

36.7

18.8

136.23

136.51

g/l

0.34

1604

15675

(3006922) Hepatitis E virus Ab [Presence] in Serum

124

2.36

4.42

1.1

—

(3011412) CD3 cells [#/volume] in Blood

137

2.29

4.39

1.2

2.6

1492.77

1285.29

e6/l

0.48

123

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

2.84

4.39

3.7

2.1

112.90

149.15

nmol/l

1.55

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

155

1101

1.45

4.39

2.5

2.4

18.99

19.18

au/ml

0.01

153

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

384

1.75

4.35

1.5

1.3

238.98

227.21

u/ml

0.18

253

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

3.22

4.34

1.1

1.2

—

(3045424) Erythrocytes [Presence] in Urine

646

1.57

4.21

2.1

2.0

0.00

1.07

estimate

0.51

239

(3006576) Bicarbonate [Moles/volume] in Blood

4.14

4.21

5.9

7.9

28.33

24.68

mmol/l

2.20

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

153

2.18

4.19

1.2

1.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

115

2.37

4.17

2.9

1.9

26.84

15.74

mg/l

1.12

(3023419) Bacteria identified in Sputum by Culture

147

2.20

4.16

1.9

2.9

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

149

2.17

4.03

1.3

—

nmol/l

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

525

1.61

4.03

2.2

—

(3042517) Benzodiazepines panel - Urine

5.03

4.00

1.5

2.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

319

1.78

3.99

1.6

497.46

368.13

mu/l

0.30

258

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

2.83

3.96

1.1

0.32

0.29

g/l

0.84

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.73

3.92

1.2

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

100

2.42

3.90

1.3

2.5

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

100

2.42

3.90

1.2

1.0

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

635

1.54

3.87

3.5

128.64

132.74

g/l

0.94

619

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.79

3.86

1.2

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

142

1018

1.43

3.85

1.8

1.6

292.17

288.44

mu/l

0.05

131

923

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

295

1.79

3.77

3.8

2.7

1.03

0.90

nmol/l

0.62

257

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

260

2061

1.31

3.76

1.8

1.9

—

(3012441) Differential panel - Pleural fluid

2.75

3.76

1.2

1.5

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

303

1.77

3.75

1.3

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

1180

0.64

3.74

1.5

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.49

3.63

1.5

3.1

589.43

990.49

u/ml

0.71

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

103

702

1.50

3.63

1.6

1.4

—

(3049717) Cytology report of Urine Cyto stain

285

1.78

3.59

2.9

2.4

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

2.96

3.57

1.5

1.6

—

(3037756) Immunofixation for Serum or Plasma

171

2.01

3.55

1.4

1.7

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.52

3.55

1.0

1.1

—

(3022689) Creatine [Moles/volume] in Urine

3.89

3.49

1.1

1.7

6.48

12.32

mmol/l

1.43

(40768441) Liver Pathology biopsy report

2.38

3.49

1.1

1.6

—

(4024509) Urine culture

521

1.56

3.48

1.7

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.90

3.46

2.0

2.1

17.83

16.37

umol/l

0.13

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

106

2.28

3.46

1.3

2.6

596.74

525.21

e6/l

0.22

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

113

2.23

3.42

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

153

2.05

3.41

1.2

1.3

0.17

0.29

nmol/l

0.45

112

(3013139) Helicobacter pylori Ag [Presence] in Stool

138

1007

1.40

3.41

1.1

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

174

1.97

3.40

1.7

1.4

22.05

24.45

ng/l

0.25

174

(4146454) Self-monitoring of blood glucose

2.40

3.40

2.6

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

3.77

3.39

1.1

1.7

9.87

10.91

g/l

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

140

2.09

3.38

1.8

1.5

1.35

1.30

promille

0.05

112

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

336

1.69

3.38

1.4

1.6

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

3.11

3.37

1.0

1.4

98.23

93.69

0.24

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.02

3.36

2.4

2.9

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

7.02

3.36

1.1

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

337

1.69

3.35

1.7

1.5

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

625

1.50

3.31

1.7

1.6

9.53

9.58

u/ml

0.00

167

(3002619) Bacteria identified in Specimen by Culture

3.44

3.31

1.7

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

176

1.95

3.30

1.2

1.4

0.60

0.56

nmol/l

0.30

169

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

122

877

1.42

3.29

1.4

1.3

217.60

229.01

miu/ml

0.14

443

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

2.79

3.25

1.7

1.6

74.59

90.66

ng/l

0.56

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

137

1832

0.72

3.25

1.4

1.6

770.86

995.84

mu/l

2.06

112

1544

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

302

1.71

3.24

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

2.40

3.23

3.7

2.7

1803.05

1239.94

0.60

(44813793) Dust mix specific IgE antibody measurement

116

2.17

3.23

1.1

1.0

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

172

1.94

3.15

2.2

4.5

3279.17

299.83

u/ml

0.45

161

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

111

2.18

3.13

1.3

2.7

197.74

210.61

e6/l

0.12

(3028433) Virus identified in Specimen by Culture

3.19

3.05

1.2

1.5

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

301

1.68

3.01

1.4

1.5

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

136

1015

1.37

2.97

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

232

1870

1.28

2.96

2.0

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

2.33

2.91

1.3

1.6

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

136

2.00

2.86

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

353

1.61

2.84

1.4

1.7

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

1316

12604

1.23

2.74

28.7

14.8

13.81

13.34

34.00

1308

12443

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

889

0.65

2.71

1.0

1.1

1.48

1.53

g/l

1.11

889

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

132

1.99

2.71

1.3

1.2

74.00

318.70

titre

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

139

1.96

2.71

1.1

—

(3010838) Calcium [Moles/time] in 24 hour Urine

234

1.73

2.70

1.9

2.0

4.69

5.08

mmol/24h

0.39

211

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

3.01

2.69

2.1

2.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

126

2.00

2.66

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.47

2.62

1.1

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

184

1.81

2.62

1.2

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

905

0.66

2.61

1.0

1.1

0.86

0.88

g/l

0.32

905

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

4.68

2.60

2.0

2.4

26.86

19.79

mg/l

—

(4035726) Immunohistochemistry procedure

134

1021

1.34

2.59

1.3

1.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

492

1.48

2.58

1.1

0.60

5.57

eliau/ml

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

261

1.67

2.56

1.5

1.4

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

171

1.83

2.55

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

3.24

2.52

1.0

1.1

—

(3017509) Phencyclidine [Presence] in Urine

3.47

2.48

3.8

1.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

256

1.66

2.47

7.4

2.9

9.10

7.67

pmol/l

0.28

256

(3044927) Protein electrophoresis panel - Urine

2.25

2.44

1.1

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

360

1.55

2.42

1.2

1.3

3.90

3.61

mmol/l

0.95

343

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

271

2277

1.23

2.42

2.3

2.1

—

(3018333) Ribosomal P Ab [Presence] in Serum

124

1.95

2.41

1.0

1.1

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1205

11494

1.19

2.37

3.9

3.7

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

4.13

2.36

2.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

3.04

2.35

1.2

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.83

2.34

1.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.83

2.34

1.0

1.2

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

2.10

2.33

3.3

2.3

—

(3008295) Osmolality of Serum or Plasma

133

1.89

2.32

1.6

277.56

282.60

mosm/kgh2o

0.56

104

(3020876) Protein [Mass/time] in 24 hour Urine

126

1.92

2.31

2.0

2.8

0.84

1.23

g/24h

0.82

(3000093) Morphology [Interpretation] in Blood Narrative

2.08

2.27

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.63

2.27

17.3

3.1

4.33

7.54

mmol/l

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

134

1.88

2.27

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

135

1.87

2.22

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.87

2.21

1.4

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

101

1.99

2.16

1.7

1.4

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

189

1.71

2.14

1.6

1.5

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

2.79

2.14

3.2

5.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

198

1.68

2.09

1.4

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.91

2.07

1.2

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.91

2.07

1.3

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

5.01

2.07

1.2

1.3

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

161

1.75

2.06

1.1

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

525

1.41

2.06

1.8

35.74

41.09

nmol/l

1.48

516

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

132

1.83

2.04

1.0

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

4.01

2.04

1.7

1.9

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

185

1.69

2.01

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

2.82

2.00

2.6

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

105

1.92

1.96

1.3

1.2

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

210

1.63

1.95

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

210

1.63

1.95

1.4

1.3

—

(3051611) Lipemic interference index of Serum or Plasma

1.95

2.6

3.5

13.55

13.98

index

0.07

(3044290) Cell count panel - Cerebral spinal fluid

330

1.50

1.95

1.4

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

4.56

1.94

1.0

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

120

1.84

1.93

1.7

1.1

116.86

111.95

pmol/l

0.16

120

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

127

1006

1.28

1.92

2.7

2.4

71.05

77.95

ml/min/173m2

0.68

397

(40768806) Pleura Pathology biopsy report

2.16

1.88

1.6

1.8

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1173

0.75

1.87

1.7

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

237

1.57

1.85

1.6

1.9

—

1751.11

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.99

1.85

1.3

1.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

206

1.61

1.83

1.4

1.8

—

(3007463) Buprenorphine [Presence] in Urine

4.18

1.82

3.6

4.4

—

(3004616) Nuclear Ab [Presence] in Serum

183

1.65

1.82

1.4

1.3

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

2.27

1.81

1.5

1.3

119.87

90.61

nmol/l

0.23

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

247

1.55

1.79

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.77

1.79

1.4

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.18

1.78

1.4

1.5

5028.17

16961.10

e6/l

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

3.34

1.74

2.0

1.3

—

(3033799) Differential panel - Peritoneal fluid

2.67

1.72

1.8

1.5

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.92

1.72

1.3

1.2

1.16

1.19

mmol/l

—

(3015956) Eosinophils/Leukocytes in Blood by Manual count

2.92

1.72

1.4

1.6

2.86

2.85

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

140

1.72

1.1

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

365

1.44

1.72

1.3

1.4

404.17

11675.36

e6/l

0.56

286

(3010144) Erythrocytes [#/volume] in Synovial fluid

103

1.85

1.72

1.3

341938.64

72388.97

e6/l

0.54

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

357

1.44

1.71

1.3

97.29

21.55

e6/l

0.96

268

(3002079) Sodium [Moles/time] in 24 hour Urine

2.07

1.70

1.1

1.4

160.79

172.10

mmol/24h

0.19

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

405

0.61

1.68

1.7

1.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.17

1.66

1.0

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.59

1.66

1.3

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.59

1.66

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

318

1.46

1.65

1.8

1.5

146.22

152.35

au/ml

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.81

1.65

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

2.04

1.64

1.4

6719.38

2528.63

e6/l

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.94

1.64

1.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

158

1.66

1.62

1.3

1.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.07

1.60

1.3

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.07

1.60

1.3

1.8

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.07

1.60

1.3

1.8

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.07

1.60

1.3

1.8

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.01

1.58

1.3

1.1

0.07

0.02

u/ml

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

2.21

1.57

1.0

—

(3004451) EKG impression Narrative

2.21

1.57

1.3

1.2

—

(3022621) pH of Urine by Test strip

138

1138

1.23

1.53

2.9

1.9

6.00

6.14

0.76

716

(3030313) Adrenal Ab [Titer] in Serum

2.86

1.50

1.0

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

2.86

1.50

6.2

9.3

8.62

11.03

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.16

1.50

1.0

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.44

1.48

1.1

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.38

1.45

1.1

1.5

—

(3014271) Vancomycin [Susceptibility]

2.51

1.45

3.1

2.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

3.13

1.44

1.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

164

1.59

1.43

1.3

1.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.73

1.43

1.0

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

2.42

1.39

4.7

2.5

37.53

42.77

g/l

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

104

1.74

1.37

1.3

1.6

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

104

1.74

1.37

1.3

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

104

1.74

1.37

1.3

1.6

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.95

1.36

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

159

1.58

1.35

1.2

1.3

278.88

394.11

pmol/l

1.54

136

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

175

1.55

1.34

1.1

—

(40758292) HTLV I+II Ab panel - Serum

0.00

1.34

0.0

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.13

1.33

2.6

3.0

0.95

1.23

—

(3000060) B lymphocytes [#/volume] in Blood

2.04

1.33

1.4

2.2

0.20

0.16

e9/l

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.04

1.33

6.2

2.7

10.72

8.39

mmol/l

0.65

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

138

1.60

1.26

1.5

1.9

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.83

1.25

1.1

133.79

171.42

iu/ml

0.52

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

162

1388

1.19

1.24

1.2

143.57

155.40

u/ml

0.10

547

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

378

3445

1.13

1.24

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

1.77

1.23

1.3

6.27

6.17

mmol/l

0.05

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

1.94

1.17

1.1

1.2

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

355

0.67

1.14

1.0

4.35

0.26

u/ml

—

108

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

493

1.29

1.14

2.4

2.2

2.28

4.00

iu/l

2.43

222

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

138

1610

0.84

1.13

2.4

2.7

0.60

0.70

ug/l

0.99

873

(3041806) Other cells [#/volume] in Blood by Manual count

111

0.45

1.13

1.0

1.5

0.64

0.50

e9/l

—

111

(3016018) Differential panel - Cerebral spinal fluid

159

1.52

1.12

1.5

1.3

—

(40768446) Kidney Pathology biopsy report

1.90

1.12

2.7

1.6

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

120

1.59

1.08

1.2

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

177

1.48

1.08

1.9

2.4

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

298

1.35

1.03

1.3

3.20

4.83

u/ml

—

106

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

138

1.53

1.03

1.9

1.6

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

114

1.59

1.02

1.3

—

36.33

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.92

1.02

1.8

1.4

12.71

7.82

ug/l

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.88

1.00

1.1

2.8

2.27

2.03

ratio

—

(37208534) Antinuclear antibody arbitrary concentration in serum

1.84

0.98

1.1

—

(44806071) Cardiolipin IgM antibody measurement

2.18

0.98

1.0

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

1.64

0.97

1.3

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

124

1.54

0.97

1.6

2.0

—

(21494814) CD8 cells/Lymphocytes in Specimen

1.80

0.96

1.0

2.3

27.89

30.06

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.74

0.96

1.3

1.5

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.74

0.96

1.1

1.2

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

409

0.73

0.94

1.2

1.1

11.81

3.90

u/ml

0.55

203

(3042733) HLA Ab [Presence] in Serum

1.77

0.94

6.1

4.5

—

(3028717) Thiamine [Mass/volume] in Blood

2.23

0.93

1.2

56.17

65.63

ug/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.72

0.92

1.3

1.6

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

0.91

9.7

3.4

5.16

4.74

kpa

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.15

0.91

9.7

3.4

11.85

10.90

kpa

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

451

0.75

0.90

1.2

1.1

3.11

1.78

u/ml

0.34

219

(3023430) Cat dander IgE Ab [Units/volume] in Serum

381

0.73

0.88

1.1

8.02

4.92

u/ml

—

168

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

316

1.31

0.87

1.3

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

2.00

0.87

6.3

7.8

6.42

5.94

kpa

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

2.00

0.87

6.3

7.7

4.60

5.10

kpa

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

477

1.25

0.87

1.3

1.1

3.00

4.15

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

568

1.22

0.86

1.6

1.3

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

1.82

0.86

1.0

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

137

1.47

0.84

1.3

1.2

—

38.86

—

(3051651) Icteric interference index of Serum or Plasma

1.70

0.82

2.6

4.0

0.45

0.77

index

0.74

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.65

0.81

1.3

1.5

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

759

1.18

0.79

1.4

1.5

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.67

0.78

2.3

1.4

12.18

13.34

pmol/l

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.67

0.78

1.2

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

208

1.35

0.77

1.3

1.7

—

(42529406) Shigella sp [Presence] in Stool by Culture

403

1.25

0.77

1.2

—

(3045788) Cell count panel - Pleural fluid

1.70

0.76

1.5

1.4

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.65

0.75

1.0

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

792

1.17

0.74

1.7

1.5

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.00

0.72

4.2

3.6

3.60

4.52

ug/l

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

398

1.24

0.72

1.2

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

109

0.55

0.72

1.2

2.0

—

1.58

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.75

0.71

2.4

3.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

300

1.27

0.71

1.3

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

354

1.25

0.71

1.1

—

(3001556) Androgen free Index in Serum or Plasma

1.93

0.70

1.0

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

274

1.28

0.70

1.2

1.1

116.00

116.70

0.06

255

(4133840) Spirometry

1.71

0.70

1.0

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

400

1.23

0.70

1.2

—

(3003694) ABO and Rh group [Type] in Blood

527

5020

1.07

0.67

1.6

1.7

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.52

0.66

6.5

1.6

—

(1761868) Lipid panel - Serum or Plasma

649

6749

0.94

0.65

3.2

2.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

404

1.22

0.65

1.9

2.3

8.55

4.79

umol/l

0.53

300

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

783

0.85

0.63

1.8

—

(4195642) Thrombophilia screening test

270

1.26

0.62

1.3

1.2

—

(3033099) Centromere Ab [Titer] in Serum

1.67

0.61

1.2

—

(3017569) Oxygen content in Arterial blood

1.60

0.61

10.5

3.1

15.88

16.85

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

0.00

0.60

0.0

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

874

0.86

0.60

1.6

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

108

960

1.13

0.60

1.5

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

473

1.19

0.59

2.1

2.6

176.55

171.43

0.15

461

(3024263) Appearance of Synovial fluid

1.51

0.58

2.5

1.7

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.58

0.0

1.6

—

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

1268

12879

0.93

0.58

29.5

15.1

331.38

333.14

g/l

9.86

1262

12803

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

319

1.23

0.57

2.2

1.8

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

211

1.28

0.57

1.2

1.1

101.96

96.70

0.59

201

(40768795) Lymph node Pathology biopsy report

124

1.37

0.55

1.3

1.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

123

0.65

0.54

1.0

1.1

—

(44790048) Parainfluenza type 2 nucleic acid detection

195

1.29

0.54

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

195

1.29

0.54

1.5

—

(44790047) Parainfluenza type 1 nucleic acid detection

195

1.29

0.54

1.5

—

(44790049) Parainfluenza type 3 nucleic acid detection

195

1.29

0.54

1.5

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

249

1.25

0.54

1.2

1.4

7.22

7.02

mmol/l

0.17

226

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.48

0.53

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

295

1.23

0.53

1.4

1.3

2.92

3.94

u/ml

0.28

129

(3019832) Treponema pallidum Ab [Presence] in Serum

336

3181

1.07

0.52

1.9

—

(3000330) Specific gravity of Urine by Test strip

556

1.16

0.51

2.0

2.5

1.02

ratio

0.03

506

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.42

0.50

3.2

3.7

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

686

0.87

0.47

1.3

1.5

46.03

60.63

ug/l

2.85

686

(3032773) Endomysium IgG Ab [Titer] in Serum

182

1.27

0.46

1.2

1.1

—

(3036489) Thrombin time

581

1.14

0.45

1.8

2.2

20.00

20.58

0.70

513

(3024891) Influenza virus A+B Ag [Presence] in Specimen

479

1.15

0.44

1.2

1.1

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

1.37

0.44

1.0

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

148

1.29

0.43

1.1

—

(3045142) Bone marrow Pathology biopsy report

127

0.71

0.43

1.0

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

332

1.18

0.42

1.2

1.1

30.98

12.69

au/ml

—

108

(3025577) Chromium [Mass/volume] in Blood

1.52

0.41

2.0

2.3

1.60

1.91

ug/l

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

1.36

0.41

1.3

1.2

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.31

0.39

1.3

1.2

256.63

471.44

u/l

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

0.00

0.39

0.0

1.1

—

75.79

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.35

0.37

1.0

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.35

0.37

1.0

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.43

0.35

1.0

1.1

0.11

7.98

u/ml

—

(3039443) Prostate specific Ag panel - Serum or Plasma

221

0.81

0.33

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

273

2612

1.05

0.33

3.6

4.2

1.22

1.85

ug/l

3.75

252

2402

(3025018) Bordetella pertussis Ab [Titer] in Serum

129

1.24

0.30

1.4

1.2

—

(3026250) Tacrolimus [Mass/volume] in Blood

1.34

0.30

65.2

38.5

7.95

7.19

ug/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.32

0.28

1.0

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

247

0.85

0.27

1.6

1.7

8.07

7.71

mmol/l

0.24

238

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

235

0.85

0.25

1.2

1.6

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

292

1.13

0.25

1.2

1.1

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

114

1.23

0.25

1.1

1.2

12.29

8.02

mm/h

0.81

114

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

464

1.10

0.25

1.4

0.33

0.45

nmol/l

0.88

377

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

455

0.90

0.24

1.2

1.4

3.06

3.49

ug/l

0.28

423

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.74

0.24

1.3

2.8

27.65

115.62

ug/l

—

(3035285) Chloride [Moles/volume] in Venous blood

0.75

0.22

2.7

2.4

104.71

105.96

mmol/l

—

(3041354) Potassium [Moles/volume] in Venous blood

0.75

0.22

2.7

2.4

3.83

3.93

mmol/l

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.25

0.22

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.74

0.22

1.3

1.0

—

(40768793) Breast Pathology biopsy report

381

1.11

0.22

1.2

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

524

0.91

0.22

1.2

1.1

1.50

2.69

u/ml

0.94

269

(3003740) Influenza virus B Ag [Presence] in Specimen

420

0.90

0.22

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

420

0.90

0.22

1.1

—

(3011897) Casein IgE Ab [Units/volume] in Serum

1.22

0.22

1.2

1.1

0.02

0.39

u/ml

—

(3008037) Lactate [Moles/volume] in Venous blood

229

1.14

0.21

2.7

1.38

1.48

mmol/l

0.41

218

(3023410) Appearance of Cerebral spinal fluid

163

1.17

0.21

1.4

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.21

0.0

1.5

—

0.15

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

3.3

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.21

0.0

2.9

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3016031) Almond IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.10

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.21

0.0

1.0

—

9.60

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

1.2

2.0

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

1.25

0.20

1.2

2.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.18

0.19

3.7

1.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.24

0.18

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

476

0.92

0.18

1.1

9.31

5.50

u/ml

0.53

254

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.17

0.17

1.1

1.2

27.29

71.28

ug/l

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

301

1.10

0.17

1.1

1.75

2.15

eliau/ml

0.27

150

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.75

0.17

1.0

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

0.79

0.15

1.0

0.17

1.52

u/ml

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

0.78

0.15

1.2

—

(3025130) Human papilloma virus identified in Specimen

390

0.92

0.15

2.1

1.9

—

(21494434) Karyotype in Bone marrow

0.79

0.14

1.0

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.78

0.14

2.7

2.4

1.19

mmol/l

—

(4034850) Laboratory test

409

0.93

0.14

11.8

8.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

450

0.93

0.14

1.1

2.77

1.53

u/ml

0.33

184

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

272

2779

0.97

0.13

1.8

1.6

—

(1761482) Bacteria [#/volume] in Urine by Culture

210

1.10

0.12

2.3

3.1

—

(4268621) Lupus anticoagulant assay

210

1.10

0.12

2.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

1.16

0.11

1.3

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

719

0.96

0.10

2.0

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.09

0.09

1.2

1.9

75.12

50.21

ug/l

—

(3024932) HLA-DR beta [Type]

1.06

0.09

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

145

0.90

0.09

1.5

1.7

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.04

0.09

1.2

2.0

—

(3024471) HLA-A [Type]

1.04

0.09

1.0

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

155

1.10

0.09

1.2

1.7

—

(3020650) Glucose [Presence] in Urine

1.09

0.08

1.7

1.6

0.43

0.05

estimate

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.08

0.08

1.0

1.1

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

157

1.08

0.07

1.2

8.06

16.56

u/ml

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

206

1.07

0.07

4.5

4.2

24.27

24.64

u/ml

0.02

201

(3038177) Helicobacter pylori Ab [Presence] in Serum

305

0.95

0.06

1.3

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

104

0.86

0.06

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

119

1.09

0.06

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

232

0.95

0.05

1.4

1.3

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

130

1.08

0.04

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

148

0.95

0.02

1.0

0.17

3.50

u/ml

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

123

1.06

0.01

1.2

1.0

0.94

1.08

u/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

1.02

0.00

1.3

1.4

140.96

159.90

pmol/l

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

108

1.02

0.00

6.6

3.4

39.44

57.85

u/ml

0.31

108

(44806420) Estimation of glomerular filtration rate

202

0.99

0.00

2.7

2.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

209

2089

1.00

0.00

3.2

3.7

23.37

21.48

0.61

805

(4281824) Cell count and differential, peritoneal fluid

137

1.02

0.00

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

257

1.01

0.00

4.4

3.3

25.28

22.66

mg/l

0.16

175

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

2.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3033086) Enterovirus Ab [Titer] in Serum

0.00

0.0

1.0

—

(3041184) Isoniazid [Presence] in Urine

0.00

0.0

1.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(3006462) Nitrate [Presence] in Urine

0.89

0.00

1.8

2.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.0

1.2

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

7.68

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

-0.00

0.0

1.3

—

3.02

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

-0.00

0.0

1.2

—

66.38

—

(3006598) pH of Arterial cord blood

0.00

-0.00

0.0

1.3

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

0.00

-0.00

0.0

1.0

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

1.00

-0.00

1.1

1.2

98.49

51.20

u/ml

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

4.00

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

180

1.00

-0.00

2.8

2.9

7.37

7.23

mmol/l

0.08

172

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

-0.00

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

-0.00

0.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

4.0

—

103.00

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.92

-0.00

1.6

1.8

—

(4211845) Urine protein measurement

0.91

-0.00

1.7

2.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

-0.00

0.0

1.0

—

1486.33

—

(40758358) Immune stain study

0.00

-0.00

0.0

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

(40760410) HLA-B [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.00

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

-0.00

0.0

1.0

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

-0.00

0.0

1.0

—

(3022670) pH of Venous cord blood

0.00

-0.00

0.0

1.1

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

-0.00

0.0

1.0

—

7514.00

—

(40760409) HLA-A [Type] by High resolution

0.00

-0.00

0.0

1.0

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

-0.00

0.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_HIDRADENITISSUP and mortality.

Females

Parameter	HR [95% CI]	p-value
L12_HIDRADENITISSUP	2.542 [2.09, 3.09]	< 0.001
Birth year	0.992 [0.98, 1.0]	0.08

During the follow-up period (1.1.1998 — 31.12.2019), 168 out of 3437 females with L12_HIDRADENITISSUP died.

Males

Parameter	HR [95% CI]	p-value
L12_HIDRADENITISSUP	2.558 [2.19, 2.99]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 286 out of 2336 males with L12_HIDRADENITISSUP died.

Mortality risk

Mortality risk for people of age

years, who have L12_HIDRADENITISSUP.

N-year risk	Females	Males
1	0.225%	0.52%
5	1.414%	2.929%
10	3.201%	7.481%
15	6.359%	14.047%
20	11.188%	22.631%

Relationships between endpoints

↥

Index endpoint: L12_HIDRADENITISSUP – Hidradenitis suppurativa

GWS hits: 4

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Hidradenitis suppurativa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints